Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model
Open accessAbstract
TREM2 is an Alzheimer's disease (AD) risk gene expressed in microglia. To study the role of Trem2 in a mouse model of β-amyloidosis, we compared PS2APP transgenic mice versus PS2APP mice lacking Trem2 (PS2APP;Trem2 ko ) at ages ranging from 4 to 22 months. Microgliosis was impaired in PS2APP;Trem2 ko mice, with Trem2 -deficient microglia showing compromised expression of proliferation/Wnt-related genes and marked accumulation of ApoE. Plaque abundance was elevated in PS2APP;Trem2 ko females at 6–7 months; but by 12 or 19–22 months of age, it was notably diminished in female and male PS2APP;Trem2 ko mice, respectively. Across all ages, plaque morphology was more diffuse in PS2APP;Trem2 ko brains, and the Aβ42:Aβ40 ratio was elevated. The amount of soluble, fibrillar Aβ oligomers also increased in PS2APP;Trem2 ko hippocampi. Associated with these changes, axonal dystrophy was exacerbated from 6 to 7 months onward in PS2APP;Trem2 ko mice, notwithstanding the reduced plaque load at later ages. PS2APP;Trem2 ko mice also exhibited more dendritic spine loss around plaque and more neurofilament light chain in CSF. Thus, aggravated neuritic dystrophy is a more consistent outcome of Trem2 deficiency than amyloid plaque load, suggesting that the microglial packing of Aβ into dense plaque is an important neuroprotective activity. SIGNIFICANCE STATEMENT Genetic studies indicate that TREM2 gene mutations confer increased Alzheimer's disease (AD) risk. We studied the effects of Trem2 deletion in the PS2APP mouse AD model, in which overproduction of Aβ peptide leads to amyloid plaque formation and associated neuritic dystrophy. Interestingly, neuritic dystrophies were intensified in the brains of Trem2 -deficient mice, despite these mice displaying reduced plaque accumulation at later ages (12–22 months). Microglial clustering around plaques was impaired, plaques were more diffuse, and the Aβ42:Aβ40 ratio and amount of soluble, fibrillar Aβ oligomers were elevated in Trem2 -deficient brains. These results suggest that the Trem2-dependent compaction of Aβ into dense plaques is a protective microglial activity, limiting the exposure of neurons to toxic Aβ species.
AI snapshot
Written from the paper’s full text.
TL;DR
In PS2APP mice, Trem2 deletion impairs plaque-associated microgliosis and shifts amyloid pathology toward a more diffuse, Aβ42-enriched form, with reduced late-stage plaque load but worse axonal dystrophy and spine loss. The authors conclude that Trem2-dependent microglial activation is mainly neuroprotective in β-amyloidosis and that neuronal pathology is a better readout than plaque load.
Key findings
- Trem2 deletion impaired microglial responses to plaque: reduced Iba1+ clusters, CD68 staining, CD45high microglia, and methoxy-X04+ amyloid-containing microglia across ages; RNAseq found 144 transcripts reduced and only 7 increased in PS2APP;Trem2ko microglia (≥2-fold, adjusted p ≤ 0.05), including impaired proliferation/Wnt-related genes.
- Plaque effects were age- and sex-dependent: plaque load was increased in 6–7 month PS2APP;Trem2ko females, but reduced in 12 month females and 19–22 month males; plaques were more diffuse in Trem2ko brains at all ages tested, and amber cores were reduced in Trem2het and nearly absent in Trem2ko aged males.
- Aβ42:Aβ40 ratio was elevated in PS2APP;Trem2ko brains in both TBS and GuHCl fractions across ages, with increased soluble fibrillar oligomers by OC dot blot; ApoE accumulated in Trem2ko microglia in 12 month females despite no difference in microglial Apoe mRNA.
- Neuronal pathology worsened: plaque-associated Lamp1+ axonal dystrophy and total Lamp1+ area increased from 7 months onward in Trem2ko mice; amino cupric silver degeneration was greater at 12 months in females and 19–22 months in males; CSF NfL was significantly higher in Trem2ko mice, while plasma NfL did not differ; plaque-proximal dendritic spine density was lower in Trem2ko than Trem2wt or Trem2het mice, with spine density ~50% reduced near plaque versus distal segments.
Methods
- Compared PS2APP transgenic mice with PS2APP;Trem2ko mice across ages 4 to 22 months, using single-sex cohorts: females at 4, 6–7, and 12 months; males at 6–7 and 19–22 months, plus a 19–22 month male cohort including Trem2het mice.
- Used histology and whole-slide imaging for plaque, Iba1, CD68, Gfap, Lamp1, ApoE, and silver stains; flow cytometry/FACS for brain-resident myeloid cells; RNAseq of sorted microglia; Aβ40/Aβ42 ELISA; nondenaturing dot blots; two-photon imaging of plaque and dendritic spines; and Simoa NfL measurements in CSF/plasma.
- Main analyses included unpaired t tests, one-way ANOVA with Tukey’s multiple-comparisons, differential expression with voom+limma, GO overrepresentation, and gene set scoring.
Limitations
- Stated in the paper: RNAseq was from bulk sorted brain myeloid cells, not single-cell resolution; the CSF/plasma NfL cohort was not littermates and was assembled specifically for NfL measurements after a peer-review recommendation; aged male numbers were depleted, so available Trem2het mice were included to round out that analysis.
- Evident from the text: findings are from a mouse β-amyloidosis model and may not translate directly to human AD; several cohorts were processed as separate batches, and some flow cytometry/methoxy-X04 analyses used very small n (e.g., n = 3 Trem2wt and n = 2 Trem2ko).
- Evident from the text: the study reports histopathological and biochemical outcomes, not cognitive/behavioral measures, so the functional consequences of the observed neuronal pathology are not directly tested.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 74 cited sources checked · 0 supported · 0 flagged
- Findingown data
PS2APP;Trem2ko mice at 12 months of age have elevated neurofilament-L in the CSF.
“elevated neurofilament-L in the CSF”
Quote in the paperSubstantial claim - Findingcitation
The dependence of these transcripts on Trem2 for their induction in PS2APP microglia was approximately concordant with published data from sorted microglial populations from the 5xFAD model.
“The dependence of these transcripts on Trem2 for their induction in PS2APP microglia was approximately concordant with published data from sorted microglial populations from the 5xFAD model (Wang et al., 2015) (Fig. 2A).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wang et al., 2015
Not checked in the free run.
- Findingown data
PS2APP;Trem2ko mice at 12 months of age have increased levels of soluble fibrillar oligomeric Aβ.
“increased levels of soluble fibrillar oligomeric Aβ”
Quote in the paperSubstantial claim - Findingown data
In 12 month PS2APP;Trem2ko animals, the fraction of Iba1 and methoxy-X04 signals that colocalized with each other is significantly reduced.
“Analysis of confocal z-stack images of cortical tissue from 12 month PS2APP;Trem2ko animals also found a significant reduction in the fraction of Iba1 and methoxy-X04 signals that colocalized with each other (Fig. 1-1).”
Quote in the paperSubstantial claim - Findingcitation
Applying cutoffs of ≥2-fold change and adjusted p value ≤ 0.05, only 7 transcripts had increased abundance in PS2APP;Trem2ko versus PS2APP;Trem2wt microglia (excluding Treml1, an artifact of the KO cassette insertion).
“Applying cutoffs of ≥2-fold change and adjusted p value ≤ 0.05, we observed only 7 transcripts with increased abundance in PS2APP;Trem2ko versus PS2APP;Trem2wt microglia (excluding Treml1, an artifact of the KO cassette insertion) (Kang et al., 2018).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kang et al., 2018
Not checked in the free run.
- Findingown data
Neuritic dystrophy histopathology was more marked in PS2APP;Trem2ko mice, even at older ages when total plaque was reduced.
“neuritic dystrophy histopathology was more marked in PS2APP;Trem2ko mice, even at older ages when total plaque was reduced.”
Quote in the paperSubstantial claim - Findingown data
Plaque accumulation was reduced at older ages in both female and male PS2APP;Trem2ko mice compared with age-matched PS2APP;Trem2wt mice.
“plaque accumulation was reduced at older ages in both female and male Trem2 KO (PS2APP;Trem2ko) mice compared with age-matched Trem2 WT (PS2APP;Trem2wt) mice.”
Quote in the paperSubstantial claim - Findingcitation
In recently published microglia RNA-Seq expression profiles from the 5xFAD model, similar Trem2-dependent induction was observed for the nine above-mentioned genes, with the exception of Ptk7.
“We also analyzed recently published microglia RNA-Seq expression profiles from the 5xFAD model (Griciuc et al., 2019) and observed similar Trem2-dependent induction for the nine above-mentioned genes, with the exception of Ptk7 (Fig. 2-2B.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Griciuc et al., 2019
Not checked in the free run.
- Findingown data
Six positive factors in Wnt signaling showed reduced expression in PS2APP;Trem2ko microglia: Fzd9, Sulf2, Bambi, Ptk7, Aspm, and Dkk2.
“Supporting this interpretation, the GO knowledge base identified “positive regulation of canonical Wnt signaling pathway” as a biological process overrepresented (fold enrichment = 10.3, FDR = 0.026) among the 144 transcripts with ≥2-fold reduced abundance in PS2APP;Trem2ko microglia (Fig. 2-2A, with six positive factors in Wnt signaling showing reduced expression including Fzd9 (Karasawa et al.,”
Quote in the paperNot a substantial claim - Findingown data
Plaque morphology was more diffuse in PS2APP;Trem2ko mice.
“plaque morphology was more diffuse”
Quote in the paperSubstantial claim - Findingown data
144 transcripts (excluding Trem2) showed reduced abundance in PS2APP;Trem2ko compared with PS2APP;Trem2wt microglia using cutoffs of ≥2-fold change and adjusted p ≤ 0.05.
“In contrast, 144 transcripts (excluding Trem2) showed reduced abundance in PS2APP;Trem2ko compared with PS2APP;Trem2wt microglia using the same cutoffs (Fig. 2A; for extended data table of genome-wide expression values for each sample and summary statistics for differential gene expression, see Fig. 2-1.”
Quote in the paperSubstantial claim - Findingown data
PS2APP;Trem2ko brains show reduced staining for CD68 marking active microglial lysosomes by IHC.
“PS2APP;Trem2ko brains showed reduced staining for CD68 marking active microglial lysosomes by IHC”
Quote in the paperSubstantial claim - Findingown data
Proliferation-related transcripts in PS2APP;Trem2ko microglia are reduced, particularly those encoding certain components and regulators of Wnt-related signaling.
“Trem2-deficient microglia showing compromised expression of proliferation/Wnt-related genes”
- Also stated in: § Introduction · plain
“By RNAseq, we observed that proliferation-related transcripts in PS2APP;Trem2ko microglia were reduced, particularly those encoding certain components and regulators of Wnt-related signaling.”
Quote in the paperSubstantial claim - Also stated in: § Introduction · plain
- Findingown data
PS2APP;Trem2ko mice show a reduced percentage of methoxy-X04+ amyloid-containing microglia by flow cytometry.
“reduced percentage of methoxy-X04+ (amyloid-containing) microglia by flow cytometry”
Quote in the paperSubstantial claim - Findingown data
PS2APP;Trem2ko mice show a reduced percentage of CD45high activated microglia by flow cytometry.
“reduced percentage of CD45high (“activated”) microglia by flow cytometry”
Quote in the paperSubstantial claim - Findingcitation
Less induction of the Proliferation module was observed in Trem2ko microglia expression profiles from the 5xFAD model.
“We also observed less induction of the Proliferation module in Trem2ko microglia expression profiles from the 5xFAD model (Griciuc et al., 2019) (Fig. 2-2C).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Griciuc et al., 2019
Not checked in the free run.
- Findingown data
The GO knowledge base identified "positive regulation of canonical Wnt signaling pathway" as a biological process overrepresented (fold enrichment = 10.3, FDR = 0.026) among the 144 transcripts with ≥2-fold reduced abundance in PS2APP;Trem2ko microglia.
“Supporting this interpretation, the GO knowledge base identified “positive regulation of canonical Wnt signaling pathway” as a biological process overrepresented (fold enrichment = 10.3, FDR = 0.026) among the 144 transcripts with ≥2-fold reduced abundance in PS2APP;Trem2ko microglia (Fig. 2-2A, with six positive factors in Wnt signaling showing reduced expression including Fzd9 (Karasawa et al.,”
Quote in the paperNot a substantial claim - Findingown data
The effects of Trem2 deficiency on plaque load varied with age and sex.
“Here we report that the effects of Trem2 deficiency on plaque load varied with age and sex”
Quote in the paperSubstantial claim - Findingcitation
The majority of the 144 transcripts with reduced abundance in PS2APP;Trem2ko microglia showed upregulation in microglial expression profiles from the PS2APP model and other models of β-amyloid pathology compared with nontransgenic mice.
“The majority of these transcripts showed upregulation in microglial expression profiles from the PS2APP model (Friedman et al., 2018) and other models of β-amyloid pathology (Orre et al., 2014; Wang et al., 2015) compared with nontransgenic mice (Fig. 2A).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Friedman et al., 2018
Not checked in the free run.
- cites Orre et al., 2014
Not checked in the free run.
- cites Wang et al., 2015
Not checked in the free run.
- Findingown data
The Aβ42:Aβ40 ratio was elevated in PS2APP;Trem2ko mice.
“the Aβ42:Aβ40 ratio was elevated”
Quote in the paperSubstantial claim - Findingown data
Four of the eight most starkly reduced transcripts (by fold change) in PS2APP;Trem2ko microglia are regulators of canonical Wnt signaling or proliferation: Dkk2, Wif1, Ctnna3, and Asb11.
“Four of the eight most starkly reduced transcripts (in terms of fold change) in PS2APP;Trem2ko microglia are regulators of canonical Wnt signaling or proliferation (Dkk2, Wif1, Ctnna3, and Asb11) (Fig. 2B).”
Quote in the paperSubstantial claim - Findingown data
PS2APP;Trem2ko mice show reductions in total Iba1 and Gfap staining at later ages.
“We also observed reductions in total Iba1 and Gfap staining at the later ages”
Quote in the paperSubstantial claim - Findingown data
Microgliosis is impaired in PS2APP;Trem2ko mice, with reduced Iba1+ microglial clusters at 4, 6-7, 12, and 19-22 months compared with PS2APP;Trem2wt mice.
“Microgliosis was impaired in PS2APP;Trem2ko mice”
- Also stated in: § Plaque-associated microgliosis is impaired in PS2APP;Trem2ko microglia · plain
“We found a stark reduction in Iba1+ microglial clusters in PS2APP;Trem2ko mice at 4, 6–7, 12, and 19–22 months compared with PS2APP;Trem2wt (Fig. 1A,B).”
Quote in the paperSubstantial claim - Also stated in: § Plaque-associated microgliosis is impaired in PS2APP;Trem2ko microglia · plain
- Findingown data
Total Lamp1+ area was increased from 7 months onward in PS2APP;Trem2ko brain sections.
“Second, the total Lamp1+ area was also increased from 7 months onward in PS2APP;Trem2ko brain sections (Fig. 7D), indicating that total axonal damage was exacerbated at later ages despite the reduced plaque burden.”
Quote in the paperSubstantial claim - Findingown data
No effect of Trem2 deletion on the induction of the LPS-related and Interferon-related modules was observed.
“No effect of Trem2 deletion on the induction of the LPS-related and Interferon-related modules was observed.”
Quote in the paperNot a substantial claim - Findingown data
Microglial association with plaque was severely compromised in PS2APP;Trem2ko brains at all examined ages.
“The methoxy-X04/Iba1 costain showed that microglial association with plaque was severely compromised in PS2APP;Trem2ko brains at all examined ages (Fig. 7A,B), corroborating our earlier Iba1 immunohistochemical stains that measured microglial clustering.”
Quote in the paperSubstantial claim - Findingown data
No effect of Trem2 deletion on the low levels of plaque deposition detected at 4 months was observed.
“We did not observe any effect of Trem2 deletion on the low levels of plaque deposition detected at the earliest stage examined (4 months).”
Quote in the paperNot a substantial claim - Findingown data
Using an algorithm based on X-34 signal intensity to quantify plaque diffuseness, plaque morphologies were significantly more diffuse in PS2APP;Trem2ko brains in both sexes at all ages tested.
“Using an algorithm based on X-34 signal intensity to quantify the degree of plaque diffuseness, we observed that plaque morphologies were significantly more diffuse in PS2APP;Trem2ko brains in both sexes at all ages tested (Fig. 4B).”
Quote in the paperSubstantial claim - Findingown data
The Aβ42:Aβ40 ratio was higher in PS2APP;Trem2ko than in PS2APP;Trem2wt brains, in both TBS and GuHCl fractions across ages.
“Notably, the Aβ42:Aβ40 ratio was higher in PS2APP;Trem2ko than in PS2APP;Trem2wt brains, in both TBS and GuHCl fractions across ages (Fig. 5A,B).”
Quote in the paperSubstantial claim - Findingown data
Similar results were observed in distinct cohorts of 6 month females and 8 month males by in vivo labeling of plaque using methoxy-X04 injection, followed by fixation and two-photon imaging of intact somatosensory cortex.
“We observed similar results in distinct cohorts of 6 month females and 8 month males by in vivo labeling of plaque using methoxy-X04 injection, followed by fixation and two-photon imaging of intact somatosensory cortex (Fig. 3-1).”
Quote in the paperNot a substantial claim - Findingown data
On a per plaque basis, axonal dystrophy was exacerbated from 7 months onward in PS2APP;Trem2ko mice.
“First, on a per plaque basis, axonal dystrophy was exacerbated from 7 months onward in PS2APP;Trem2ko mice (Fig. 7C), similar to findings in other β-amyloid models (Wang et al., 2016; Yuan et al., 2016).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Wang et al., 2016
Not checked in the free run.
- cites Yuan et al., 2016
Not checked in the free run.
- Findingown data
The Neurodegeneration-related gene set was notably impaired in PS2APP;Trem2ko microglia.
“As expected, the Neurodegeneration-related gene set, which overlaps with the so-called DAM (Keren-Shaul et al., 2017) and MGnD (Krasemann et al., 2017) genes but relates more specifically to neurodegenerative disease models, was notably impaired in PS2APP;Trem2ko microglia (Fig. 2D; Fig. 2-3).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Keren-Shaul et al., 2017
Not checked in the free run.
- cites Krasemann et al., 2017
Not checked in the free run.
- Findingown data
The ApoE immunostaining pattern was especially prominent in, but not limited to, the hippocampal subiculum where plaque tends to first deposit.
“The ApoE immunostaining pattern was especially prominent in, but not limited to, the hippocampal subiculum where plaque tends to first deposit (Fig. 6B).”
Quote in the paperNot a substantial claim - Findingown data
No difference in Apoe expression was detected between PS2APP;Trem2wt and PS2APP;Trem2ko microglia at the mRNA level.
“At the mRNA level, we did not detect a difference in Apoe expression between PS2APP;Trem2wt and PS2APP;Trem2ko microglia (Fig. 6E; see also Fig. 2E).”
Quote in the paperNot a substantial claim - Findingown data
Microglia in PS2APP;Trem2ko mice were markedly laden with ApoE, in contrast to diminished ApoE labeling.
“Instead of ApoE labeling being diminished, we observed microglia in PS2APP;Trem2ko mice to be markedly laden with ApoE (Fig. 6C,D), suggesting that Trem2-deficient microglia exhibit deficits in lipid clearance.”
Quote in the paperSubstantial claim - Findingown data
X-34+ structures in PS2APP;Trem2ko brains looked more splayed and less compact than in PS2APP;Trem2wt brains.
“Although we were blinded to Trem2 genotype, there was an obvious difference in plaque appearance between PS2APP;Trem2wt and PS2APP;Trem2ko brains, with X-34+ structures in PS2APP;Trem2ko brains looking more splayed and less compact (Fig. 4A), similar to descriptions of Trem2-dependent plaque alterations in other β-amyloid models (Wang et al., 2016; Yuan et al., 2016).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Wang et al., 2016
Not checked in the free run.
- cites Yuan et al., 2016
Not checked in the free run.
- Findingown data
At 19-22 months, the Campbell-Switzer stain revealed a distinctive pattern of "amber core" amyloid staining in PS2APP brains.
“At this age, the Campbell-Switzer stain also revealed a distinctive pattern of “amber core” amyloid staining in PS2APP brains (Fig. 3C), thought to represent a mature form of highly condensed plaque.”
Quote in the paperNot a substantial claim - Findingown data
Degenerating neurites detected by amino-cupric-silver stain were more abundant in PS2APP;Trem2ko brains of the 12 month female and 19-22 month male cohorts.
“Degenerating neurites detected by this stain were more abundant in PS2APP;Trem2ko brains of the 12 month female and 19–22 month male cohorts (Fig. 8A,B).”
Quote in the paperSubstantial claim - Findingown data
An intermediate reduction in plaque load was observed in Trem2 heterozygous (PS2APP;Trem2het) mice at 19-22 months.
“An intermediate reduction in plaque load was observed in Trem2 heterozygous (PS2APP;Trem2het) mice at 19–22 months (the only age where heterozygous mice were analyzed) (Fig. 3A).”
Quote in the paperNot a substantial claim - Findingown data
Similar respective trends were seen when staining with the prefibrillar Aβ oligomer antibody A11 and pan-reactive 4G8 Aβ antibody.
“Similar respective trends were also seen when staining with the prefibrillar Aβ oligomer antibody A11 and pan-reactive 4G8 Aβ antibody (data not shown).”
Quote in the paperNot a substantial claim - Findingown data
PS2APP;Trem2ko mice had significantly greater NfL levels in the CSF compared with PS2APP;Trem2wt mice.
“PS2APP;Trem2ko mice had significantly greater NfL levels in the CSF compared with PS2APP;Trem2wt mice (Fig. 8C), consistent with the measures of increased axonal dystrophy that were observed by histopathology in Trem2-deficient females at this age.”
Quote in the paperSubstantial claim - Findingown data
In 6-month female PS2APP mice, spine density was ∼50% reduced on plaque-proximal dendrite segments (within 20 μm) relative to distal dendrite segments (≥100 μm from any plaque) from the same animals.
“Spine density was ∼50% reduced on plaque-proximal dendrite segments relative to distal dendrite segments from the same animals.”
Quote in the paperSubstantial claim - Findingown data
No difference in plasma NfL levels between genotypes was observed.
“Perhaps surprisingly, we did not observe a difference in plasma NfL levels between genotypes (Fig. 8C), suggesting that CSF NfL measurements better represent ongoing neuronal damage or degeneration in the CNS than plasma measurements.”
Quote in the paperSubstantial claim - Findingreasoning
The Aβ42:Aβ40 ratio declines as PS2APP mice age, particularly in the insoluble fraction.
“our observation that the Aβ42:Aβ40 ratio declines as the mice age, particularly in the insoluble fraction”
Quote in the paperNot a substantial claim - Findingnone given
Transcriptional induction of the neurodegeneration-related modules, the proliferation module, and certain genes related to Wnt regulation were impaired in PS2APP;Trem2ko microglia.
“Transcriptional induction of the neurodegeneration-related modules, the proliferation module, and certain genes related to Wnt regulation were impaired in PS2APP;Trem2ko microglia.”
Quote in the paperSubstantial claim - Findingreasoning
Plaques in PS2APP;Trem2ko brains displayed a more diffuse morphology than in PS2APP;Trem2wt brains.
“plaques in PS2APP;Trem2ko brains displayed a more diffuse morphology than in PS2APP;Trem2wt brains.”
Quote in the paperNot a substantial claim - Findingown data
Trem2 deletion increased the amount of NfL detected in CSF.
“Trem2 deletion also increased the amount of NfL detected in CSF.”
Quote in the paperNot a substantial claim - Interpretationown data
Measurements of neuronal pathology are more informative than plaque load as readouts of microglial modulation in models of β-amyloidosis.
“measurements of neuronal pathology are more informative than plaque load as readouts of microglial modulation in models of β-amyloidosis.”
Quote in the paperSubstantial claim - Interpretationown data
The entirety of these changes is approximately equivalent to the so-called DAM or MgND microglial activation profiles.
“The entirety of these changes is approximately equivalent to the so-called DAM (Keren-Shaul et al., 2017) or MgND (Krasemann et al., 2017) microglial activation profiles.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Keren-Shaul et al., 2017
Not checked in the free run.
- cites Krasemann et al., 2017
Not checked in the free run.
- Interpretationreasoning
The reduced expression of these transcripts in PS2APP;Trem2ko microglia is another manifestation of the impaired microglial response to β-amyloid pathology.
“Therefore, their reduced expression in PS2APP;Trem2ko microglia is another manifestation of the impaired microglial response to β-amyloid pathology.”
Quote in the paperSubstantial claim - Interpretationcitation
Trem2 deficiency impairs the ability of microglia to engage plaques and phagocytose Aβ fibrils/aggregates.
“These observations were consistent with reports of Trem2 deletion in other β-amyloidosis models (Jay et al., 2015; Wang et al., 2015, 2016; Yuan et al., 2016; Parhizkar et al., 2019) and suggested that Trem2 deficiency impairs the ability of microglia to engage plaques and phagocytose Aβ filbrils/aggregates.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Jay et al., 2015
Not checked in the free run.
- cites Wang et al., 2015, 2016
Not checked in the free run.
- cites Yuan et al., 2016
Not checked in the free run.
- Rests on an assumption: The effects of Trem2 deletion in PS2APP mice are mediated specifically by microglial Trem2 rather than by other Trem2-expressing myeloid cells or non-myeloid cells.
- Interpretationown data
Trem2-dependent microglial activity is essential for the formation of amber core amyloid structures.
“These amber cores were reduced in PS2APP;Trem2het and nearly absent in PS2APP;Trem2ko brains, indicating that Trem2-dependent microglial activity is essential for the formation of these particular amyloid structures.”
Quote in the paperSubstantial claim- Rests on an assumption: Amber core amyloid staining represents a mature form of highly condensed plaque.
- Interpretationown data
Degenerating axonal processes are not restricted to dystrophic neurites around plaques.
“Overall, the staining pattern appeared very similar to the Lamp1 stain, with “bouquets” of argyrophilic structures presumably surrounding plaques throughout the cortex and hippocampus. Staining was also observed in relevant white matter tracts, such as the corpus callosum, perforant path, and fornix, suggesting that degenerating axonal processes are not restricted to dystrophic neurites around”
Quote in the paperNot a substantial claim - Interpretationreasoning
The diffuse plaque structures and elevated Aβ42:Aβ40 ratio in Trem2ko brains are more damaging to surrounding axons than the more compacted, Aβ40-enriched plaques in PS2APP;Trem2wt brains.
“This is consistent with the idea that the diffuse plaque structures and elevated Aβ42:Aβ40 ratio in Trem2ko brains are more damaging to surrounding axons than the more compacted, Aβ40-enriched plaques in PS2APP;Trem2wt brains.”
Quote in the paperSubstantial claim - Interpretationown data
Total axonal damage was exacerbated at later ages in PS2APP;Trem2ko mice despite reduced plaque burden.
“Second, the total Lamp1+ area was also increased from 7 months onward in PS2APP;Trem2ko brain sections (Fig. 7D), indicating that total axonal damage was exacerbated at later ages despite the reduced plaque burden.”
Quote in the paperSubstantial claim - Interpretationown data
In the absence of Trem2, the increased Aβ42:Aβ40 ratio enhances the potential shift of soluble Aβ to a fibrillar oligomeric form.
“These results suggest that, in the absence of Trem2, the increased Aβ42:Aβ40 ratio enhances the potential shift of soluble Aβ to a fibrillar oligomeric form.”
Quote in the paperSubstantial claim - Interpretationcitation
The authors' results are similar to previous analysis of the 5xFAD model, in which microglial induction of many DAM genes showed substantial Trem2 dependence whereas downregulation of microglial "homeostatic" genes appeared largely Trem2-independent.
“Overall, our results are similar to previous analysis of the 5xFAD model, in which the microglial induction of many DAM genes showed substantial Trem2 dependence whereas the downregulation of so-called microglial “homeostatic” genes appeared largely Trem2-independent (Keren-Shaul et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Keren-Shaul et al., 2017
Not checked in the free run.
- Interpretationcitation
Reductions in microglial Apoe expression in the APPPS1 model when Trem2 is deleted do not appear to be a typical feature of Trem2 deficiency in β-amyloidosis models, since previous analyses in the 5xFAD model observed Trem2-independent Apoe induction.
“Although two groups have reported reductions in microglial Apoe expression in the APPPS1 model when Trem2 is deleted (Krasemann et al., 2017; Parhizkar et al., 2019), this does not appear to be a typical feature of Trem2 deficiency in β-amyloidosis models since previous analyses in the 5xFAD model observed Trem2-independent Apoe induction in either bulk microglia microarray (Fig. 6F) (Wang et al.,”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Krasemann et al., 2017
Not checked in the free run.
- cites Parhizkar et al., 2019
Not checked in the free run.
- cites Wang et al., 2015
Not checked in the free run.
- Interpretationown data
The Trem2-dependent clustering of microglia and their functions around plaque serve to mitigate the neurotoxic effects of Aβ.
“These data strongly suggest that the Trem2-dependent clustering of microglia and their functions around plaque serve to mitigate the neurotoxic effects of Aβ.”
Quote in the paperSubstantial claim - Interpretationown data
Trem2-deficient microglia exhibit deficits in lipid clearance.
“Instead of ApoE labeling being diminished, we observed microglia in PS2APP;Trem2ko mice to be markedly laden with ApoE (Fig. 6C,D), suggesting that Trem2-deficient microglia exhibit deficits in lipid clearance.”
Quote in the paperSubstantial claim - Interpretationown data
Axonal damage was exacerbated in Trem2-deficient mice from older ages despite reduced plaque accumulation.
“Thus, again, axonal damage was exacerbated in Trem2-deficient mice from older ages despite the fact that plaque accumulation was reduced.”
Quote in the paperSubstantial claim - Interpretationreasoning
The more diffuse plaque morphology in PS2APP;Trem2ko brains is presumably a consequence of the impaired microglial response around plaque.
“Presumably as a consequence of the impaired microglial response around plaque, plaques in PS2APP;Trem2ko brains displayed a more diffuse morphology than in PS2APP;Trem2wt brains.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Trem2-mediated microgliosis facilitates the consolidation of β-amyloid into a highly compacted, less damaging form.
“Trem2-mediated microgliosis facilitates the consolidation of β-amyloid into a highly compacted, less damaging form.”
Quote in the paperSubstantial claim - Interpretationreasoning
The decline in Aβ42:Aβ40 ratio with age is consistent with the accumulation of compact plaques in size and number over time in the brains of PS2APP mice.
“is consistent with the accumulation of compact plaques in size and number over time in the brains of PS2APP mice.”
Quote in the paperNot a substantial claim - Premisecitation
The effect of β-amyloid pathology on tau accumulation/spreading is further magnified in Trem2-deficient mice.
“a new report indicates that this effect is further magnified in Trem2-deficient mice (Leyns et al., 2019).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Leyns et al., 2019
Not checked in the free run.
- Interpretationown data
Trem2 seems to hedge against synapse loss.
“Thus, Trem2 is not required for microglia-mediated dendritic spine loss around plaque; and indeed, Trem2 seems to hedge against synapse loss.”
Quote in the paperSubstantial claim - Interpretationreasoning
The form of β-amyloid in the brain is more critical than the amount.
“The form of β-amyloid in the brain is more critical than the amount”
Quote in the paperSubstantial claim - Interpretationown data
Trem2 is not required for microglia-mediated dendritic spine loss around plaque.
“Thus, Trem2 is not required for microglia-mediated dendritic spine loss around plaque; and indeed, Trem2 seems to hedge against synapse loss.”
Quote in the paperSubstantial claim - Interpretationown data
CSF NfL measurements better represent ongoing neuronal damage or degeneration in the CNS than plasma measurements.
“Perhaps surprisingly, we did not observe a difference in plasma NfL levels between genotypes (Fig. 8C), suggesting that CSF NfL measurements better represent ongoing neuronal damage or degeneration in the CNS than plasma measurements.”
Quote in the paperSubstantial claim - Interpretationreasoning
The fact that plaques in Trem2-deficient mice are more injurious to adjacent neurites but show weaker labeling with molecular probes helps explain why cognitive decline correlates better with tau pathology and synapse loss than with brain amyloid detection.
“helps explain why cognitive decline correlates better with tau pathology and synapse loss than with brain amyloid detection.”
Quote in the paperSubstantial claim- Rests on an assumption: Cognitive decline correlates better with tau pathology and synapse loss than with brain amyloid detection.
- Premisecitation
In β-amyloid models, the reduction in synapse number requires the presence of microglia, since depleting the microglial cell population largely prevents loss of synaptic density.
“In β-amyloid models, the reduction in synapse number requires the presence of microglia since depleting the microglial cell population largely prevents loss of synaptic density (Olmos-Alonso et al., 2016; Spangenberg et al., 2016).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Olmos-Alonso et al., 2016
Not checked in the free run.
- cites Spangenberg et al., 2016
Not checked in the free run.
- Premisecitation
Aβ40 is more easily incorporated into existing dense plaque structures than Aβ42.
“Given that Aβ40 is more easily incorporated into existing dense plaque structures than Aβ42 (Condello et al., 2015)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Condello et al., 2015
Not checked in the free run.
- Interpretationreasoning
The form of microglial activation brought on by Aβ-related pathologies (the DAM state, or at least the Trem2-dependent component of it) protects neurons by limiting Aβ-induced neuronal injury.
“Together, these findings suggest that the form of microglial activation brought on by Aβ-related pathologies (the DAM state, or at least the Trem2-dependent component of it) protects neurons by limiting Aβ-induced neuronal injury.”
Quote in the paperSubstantial claim - Interpretationown data
Trem2-dependent microglial activity is fundamentally neuroprotective in β-amyloid-driven models of AD-like pathology.
“Overall, the exacerbated axonal dystrophy and dendritic spine loss observed around plaque in PS2APP;Trem2ko mice imply that Trem2-dependent microglial activity is fundamentally neuroprotective in β-amyloid-driven models of AD-like pathology.”
Quote in the paperSubstantial claim
- May combine two claims. 42
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 29
May combine two claims. The quote only partly states this claim.
Findingown dataPS2APP;Trem2ko mice at 12 months of age have ApoE-laden microglia, with marked accumulation of ApoE in Trem2-deficient microglia.
“Trem2-deficient microglia showing compromised expression of proliferation/Wnt-related genes and marked accumulation of ApoE.”
- Also stated in: § Introduction · plain
“Additional analyses of PS2APP;Trem2ko mice at 12 months of age revealed ApoE-laden microglia”
Quote in the paperNot a substantial claim- Also stated in: § Introduction · plain
May combine two claims.
Findingown dataOther GO biological processes downregulated in PS2APP;Trem2ko microglia included positive regulation of bone resorption (fold enrichment = 24.6, FDR = 0.030), protein kinase B signaling (16.2, 0.047), negative regulation of tumor necrosis factor production (14.1, 0.026), positive regulation of smooth muscle cell migration (13.9, 0.025), transmembrane receptor protein tyrosine kinase signaling (5.9
“Other GO biological processes implicated as being downregulated in PS2APP;Trem2ko microglia included positive regulation of bone resorption (fold enrichment = 24.6, FDR = 0.030), protein kinase B signaling (fold enrichment = 16.2, FDR = 0.047), negative regulation of tumor necrosis factor production (fold enrichment = 14.1, FDR = 0.026), positive regulation of smooth muscle cell migration (fold”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn PS2APP compared with nontransgenic microglia, the Neurodegeneration-related, Interferon-related, Proliferation, and LPS-related modules were upregulated, whereas the Microglia and Brain Myeloid modules were modestly but significantly downregulated.
“In PS2APP compared with nontransgenic microglia, several of these gene sets were upregulated, including the Neurodegeneration-related, Interferon-related, Proliferation, and LPS-related modules, whereas the Microglia and Brain Myeloid modules that typify microglia in their “homeostatic” or “resting” state were modestly but significantly downregulated (Fig. 2D; Fig. 2-3.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataEven though only 5 of 82 genes in the Proliferation module were upregulated strongly enough in PS2APP microglia to reach genome-wide significance (adjusted p ≤ 0.05), the overall expression of the module was clearly enriched compared with microglia from nontransgenic mice.
“For instance, even though only 5 of 82 genes in the Proliferation module were upregulated strongly enough in PS2APP microglia to reach genome-wide significance (adjusted p ≤ 0.05), the overall expression of the module was clearly enriched compared with microglia from nontransgenic mice (Fig. 2D; Fig. 2-3.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDespite only 2 of 82 genes (Ccna2 and Aspm) showing significant reduction in transcript abundance after correction for genome-wide analysis, the overall induction of the Proliferation module was compromised in PS2APP;Trem2ko microglia.
“Again, despite only 2 of 82 genes (Ccna2 and Aspm) showing significant reduction in transcript abundance after correction for genome-wide analysis, the overall induction of the Proliferation module was compromised in PS2APP;Trem2ko microglia (Fig. 2D; Fig. 2-3).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataConsistent changes in plaque compaction and composition were observed across ages and sexes in PS2APP;Trem2ko brains, in contrast to total plaque burden which varied with age or sex.
“In contrast to the effects of Trem2 deletion on total plaque burden that varied with age or sex, we observed consistent changes in plaque compaction and composition across ages and sexes.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPlaque load was reduced in 12 month PS2APP;Trem2ko females and in 19-22 month PS2APP;Trem2ko males compared with PS2APP;Trem2wt mice.
“We expected to see further exacerbation of amyloid plaque load in Trem2-deficient brains at more advanced ages, but, to our surprise, plaque load was reduced in 12 month PS2APP;Trem2ko females and in 19–22 month PS2APP;Trem2ko males compared with PS2APP;Trem2wt mice (Fig. 3A,B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWhen using the pan-reactive 6E10 Aβ antibody to detect total Aβ species in the soluble fraction, abundance trended slightly downward in PS2APP;Trem2ko mice and correlated negatively with Aβ42:Aβ40 ratio.
“In contrast, when we used the pan-reactive 6E10 Aβ antibody to detect total Aβ species in this fraction, the abundance trended slightly downward in PS2APP;Trem2ko mice and correlated negatively with Aβ42:Aβ40 ratio (Fig. 5F–H).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataUsing Campbell-Switzer silver stain, plaque burden was increased in 6-7 month PS2APP;Trem2ko females, and trending upward but not reaching significance in 6-7 month PS2APP;Trem2ko males.
“Indeed, using the Campbell-Switzer silver stain to label amyloid plaque (Campbell et al., 1987; Switzer, 2000), we observed that plaque burden was increased in 6–7 month PS2APP;Trem2ko females, and trending upward but not reaching significance in 6–7 month PS2APP;Trem2ko males (Fig. 3A,B).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Campbell et al., 1987
Not checked in the free run.
- cites Switzer, 2000
Not checked in the free run.
May combine two claims.
Findingown dataThe downregulation of the Microglia and Brain Myeloid modules that normally occurs during CNS challenge was not prevented by Trem2 deletion; expression of these modules was similar in PS2APP;Trem2wt and PS2APP;Trem2ko microglia.
“Unlike the clear requirement of Trem2 for induction of many genes in the Neurodegeneration-related gene set, the downregulation of the Microglia and Brain Myeloid modules that normally occurs during any CNS challenge (Friedman et al., 2018) was not prevented by Trem2 deletion since expression of these modules was similar in PS2APP;Trem2wt and PS2APP;Trem2ko microglia (Fig. 2D; Fig. 2-3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Friedman et al., 2018
Not checked in the free run.
May combine two claims.
Findingown dataThe elevated Aβ42:Aβ40 ratio in PS2APP;Trem2ko brains resulted more from reduced abundance of Aβ40 than from increased abundance of Aβ42, although Aβ42 abundance was elevated in the 6-7 month females, coinciding with the increased plaque deposition in that group.
“The elevated Aβ42:Aβ40 ratio in PS2APP;Trem2ko brains resulted more from reduced abundance of Aβ40 than from increased abundance of Aβ42 (Fig. 5-1), although Aβ42 abundance was elevated in the 6–7 month females, coinciding with the increased plaque deposition we observed in that group (Fig. 3A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataQuantification of plaque-associated ApoE in whole-brain sections found a significant increase in female PS2APP;Trem2ko mice at 6-7 and 12 months of age, but no significant changes in male cohorts at any age tested.
“In contrast to the findings of Parhizkar et al. (2019), quantification of plaque-associated ApoE in whole-brain sections found a significant increase in female PS2APP;Trem2ko mice at 6–7 and 12 months of age, but no significant changes in male cohorts at any age tested (Fig. 6A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUsing the conformation-specific OC antibody, significantly higher levels of soluble fibrillar Aβ oligomers were detected in the soluble fraction from PS2APP;Trem2ko mice, and a positive correlation was observed between OC+ fibrillar oligomers and the Aβ42:Aβ40 ratio.
“Using the conformation-specific OC antibody (Tomic et al., 2009), we detected significantly higher levels of soluble fibrillar Aβ oligomers in the soluble fraction from PS2APP;Trem2ko mice (Fig. 5C,D), and we observed a positive correlation between the amount of OC+ fibrillar oligomers in this fraction and the Aβ42:Aβ40 ratio (Fig. 5E).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tomic et al., 2009
Not checked in the free run.
May combine two claims.
Findingown dataOf the 134 genes in the Neurodegeneration-related set, 80 showed upregulation in PS2APP versus normal microglia, and approximately half of these showed impaired induction in PS2APP;Trem2ko microglia (adjusted p ≤ 0.05).
“Of the 134 genes in this set, 80 showed upregulation in PS2APP versus normal microglia (Friedman et al., 2018), and approximately half of these showed impaired induction in PS2APP;Trem2ko microglia (adjusted p values ≤ 0.05) (Fig. 2E).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Friedman et al., 2018
Not checked in the free run.
May combine two claims.
FindingcitationIn a recent dataset of bulk microglia RNA-Seq profiles from 5xFAD mice, a twofold decrease in the extent of Apoe induction was seen in Trem2-deficient microglia, but the gene was still highly induced relative to nontransgenic microglia.
“In a very recent dataset of bulk microglia RNA-Seq profiles from 5xFAD mice (Griciuc et al., 2019), we did see a twofold decrease in the extent of Apoe induction in Trem2-deficient microglia, but the gene was still highly induced relative to the expression level in microglia from nontransgenic mice (Fig. 6F).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Griciuc et al., 2019
Not checked in the free run.
May combine two claims.
Findingown dataThe abundance of Aβ peptides rose markedly with age while the Aβ42:Aβ40 ratio declined, particularly in the GuHCl fraction.
“The abundance of Aβ peptides rose markedly with age while the Aβ42:Aβ40 ratio declined, particularly in the GuHCl fraction (Fig. 5).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAmino-cupric-silver staining showed "bouquets" of argyrophilic structures presumably surrounding plaques throughout the cortex and hippocampus, and staining in white matter tracts such as corpus callosum, perforant path, and fornix.
“Overall, the staining pattern appeared very similar to the Lamp1 stain, with “bouquets” of argyrophilic structures presumably surrounding plaques throughout the cortex and hippocampus. Staining was also observed in relevant white matter tracts, such as the corpus callosum, perforant path, and fornix, suggesting that degenerating axonal processes are not restricted to dystrophic neurites around”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAmber cores were reduced in PS2APP;Trem2het and nearly absent in PS2APP;Trem2ko brains.
“These amber cores were reduced in PS2APP;Trem2het and nearly absent in PS2APP;Trem2ko brains, indicating that Trem2-dependent microglial activity is essential for the formation of these particular amyloid structures.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningPlaques in Trem2-deficient mice are more injurious to adjacent neurites but show weaker labeling with molecular probes (Thioflavin S, methoxy-X04 and X-34) related to those used in the clinic (11C-PiB, 18F-Florbetapir).
“The fact that plaques in Trem2-deficient mice are more injurious to adjacent neurites but show weaker labeling with molecular probes (Thioflavin S, methoxy-X04 and X-34) related to those used in the clinic (11C-PiB, 18F-Florbetapir)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPreventing the microglial response to Aβ pathology via Trem2 deletion reversed neither axonal dystrophy nor dendritic spine loss around plaque and indeed made both of these pathologies worse.
“preventing the microglial response to Aβ pathology via Trem2 deletion reversed neither axonal dystrophy nor dendritic spine loss around plaque and indeed made both of these pathologies worse.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt all ages examined, and in both sexes, microglial clustering around plaque and other measurements of microglial activation were sharply reduced in PS2APP;Trem2ko mice.
“At all ages examined, and in both sexes, microglial clustering around plaque and other measurements of microglial activation were sharply reduced in PS2APP;Trem2ko mice.”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningFrom 6-7 months onward, axonal injury was magnified in PS2APP;Trem2ko mice, even at later ages when the abundance of argyrophilic amyloid plaques was diminished.
“From 6–7 months onward, axonal injury was magnified in PS2APP;Trem2ko mice, even at later ages when the abundance of argyrophilic amyloid plaques was diminished.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTrem2 deletion has age- and sex-dependent effects on plaque abundance assessed using the Campbell-Switzer silver stain in PS2APP mice, with slightly more plaque in PS2APP;Trem2ko females at 6-7 months of age but markedly less plaque in both female and male PS2APP;Trem2ko mice at later ages.
“We observed both age- and sex-dependent effects of Trem2 deletion on plaque abundance assessed using the Campbell-Switzer silver stain, with slightly more plaque in PS2APP;Trem2ko females at 6–7 months of age but markedly less plaque in both female and male PS2APP;Trem2ko mice at later ages.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn 6-month-old female PS2APP mice, plaque-proximal dendritic spine density was not rescued by Trem2 deletion but was further reduced in PS2APP;Trem2ko mice compared with PS2APP;Trem2wt or PS2APP;Trem2het mice.
“Spine density loss in the proximity of plaques was not rescued by Trem2 deletion, but was actually further exacerbated in PS2APP;Trem2ko mice compared with PS2APP;Trem2wt or PS2APP;Trem2het groups (Fig. 9).”
- Also stated in: § Axonal dystrophy, dendritic spine loss, and CSF NfL detection are exacerbated in PS2APP;Trem2ko mice · plain
“Spine density near plaque was lower in PS2APP;Trem2ko mice than in PS2APP;Trem2wt or PS2APP;Trem2het mice.”
Quote in the paperSubstantial claim- Also stated in: § Axonal dystrophy, dendritic spine loss, and CSF NfL detection are exacerbated in PS2APP;Trem2ko mice · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTrem2 deletion in amyloidosis models has been reported to either increase or decrease phosphorylation of the endogenous tau protein.
“Trem2 deletion in amyloidosis models has also been reported to either increase or decrease phosphorylation of the endogenous tau protein (Jay et al., 2015; Wang et al., 2016).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Jay et al., 2015
Not checked in the free run.
- cites Wang et al., 2016
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationWhether Trem2 exerts protective or detrimental functions in mouse models of AD-related neuropathology has been rather unclear.
“However, whether Trem2 exerts protective or detrimental functions in mouse models of AD-related neuropathology has been rather unclear (Gratuze et al., 2018; Hansen et al., 2018; Ulland and Colonna, 2018).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Gratuze et al., 2018
Not checked in the free run.
- cites Hansen et al., 2018
Not checked in the free run.
- cites Ulland and Colonna, 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn transgenic models of cerebral β-amyloidosis, plaque load has been reported to be increased, decreased, or unchanged in mice that lack Trem2, depending on the model, age, and brain region analyzed.
“In transgenic models of cerebral β-amyloidosis, plaque load has been reportedly increased, decreased, or unchanged in mice that lack Trem2, depending on the model, age, and brain region being analyzed (Jay et al., 2015, 2017a; Wang et al., 2015, 2016; Yuan et al., 2016; Parhizkar et al., 2019).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Jay et al., 2015, 2017a
Not checked in the free run.
- cites Wang et al., 2015, 2016
Not checked in the free run.
- cites Yuan et al., 2016
Not checked in the free run.
May combine two claims.
PremisecitationTREM2 is an Alzheimer's disease risk gene expressed in microglia.
“TREM2 is an Alzheimer's disease (AD) risk gene expressed in microglia.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Guerreiro et al., 2013
Not checked in the free run.
- cites Jonsson et al., 2013
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAsb11 is important for maintaining progenitor cell activity in multiple cell types.
“Dkk2, Wif1, and Ctnna3 can all negatively regulate Wnt activity (Hsieh et al., 1999; Busby et al., 2004; Gage et al., 2008), whereas Asb11 is important for maintaining progenitor cell activity in multiple cell types (Diks et al., 2006; Tee et al., 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Diks et al., 2006
Not checked in the free run.
- cites Tee et al., 2012
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationGene expression modules defined by Friedman et al. (2018) can be used to characterize the diverse ways that microglia respond to environmental and genetic perturbations.
“We recently defined a number of gene expression modules that can be used to characterize the diverse ways that microglia respond to environmental and genetic perturbations (Friedman et al., 2018).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Friedman et al., 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll animal care and handling procedures were reviewed and approved by the Genentech Institutional Animal Care and Use Committee and were conducted in full compliance with regulatory statutes, Institutional Animal Care and Use Committee policies, and National Institutes of Health guidelines.
“All animal care and handling procedures were reviewed and approved by the Genentech Institutional Animal Care and Use Committee and were conducted in full compliance with regulatory statutes, Institutional Animal Care and Use Committee policies, and National Institutes of Health guidelines.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenWhole-slide image analyses were performed in a blinded manner.
“MATLAB (The MathWorks) running on a high-performance computing cluster was used for all whole-slide image analyses performed in a blinded manner.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenImages for X-34 stains were collected and processed blind to genotypes.
“Images were collected and processed blind to genotypes.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningTo avoid the presence of peripheral myeloid cells in the flow analysis and FACS collections, Ccr2+ cells and Ly6g+ cells were excluded.
“To avoid the presence of peripheral myeloid cells in the flow analysis and FACS collections, Ccr2+ cells (peripheral monocytes/macrophages) and Ly6g+ cells (neutrophils) were excluded.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPS2APP mice develop amyloid plaque and attendant gliosis pathologies that increase with age, with female mice accumulating the pathology more rapidly than males.
“PS2APP mice develop amyloid plaque and attendant gliosis pathologies that increase with age, with female mice accumulating the pathology more rapidly than males (Ozmen et al., 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ozmen et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningAll steps in tissue dissociation and cell suspension preparation were performed on ice or at 4°C to prevent artifactual microglial activation.
“All steps were performed on ice or at 4°C to prevent artifactual microglial activation.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe reductions in total Iba1 and Gfap staining indicate reduced extents of microgliosis and astrogliosis, respectively, in PS2APP;Trem2ko mice.
“indicative of reduced extents of microgliosis and astrogliosis, respectively, in PS2APP;Trem2ko mice”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAcquisition of the DAM state is Trem2-dependent in mouse models of AD, amyotrophic lateral sclerosis, and demyelinating disease.
“The acquisition of the DAM state is Trem2-dependent in mouse models of AD, amyotrophic lateral sclerosis, and demyelinating disease (Poliani et al., 2015; Wang et al., 2015; Keren-Shaul et al., 2017; Krasemann et al., 2017).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Poliani et al., 2015
Not checked in the free run.
- cites Wang et al., 2015
Not checked in the free run.
- cites Keren-Shaul et al., 2017
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn the hTau model, Trem2 deletion increased the amounts of tau phosphorylation and aggregation detected.
“In the hTau model (Andorfer et al., 2003), Trem2 deletion increased the amounts of tau phosphorylation and aggregation detected (Bemiller et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bemiller et al., 2017
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll images, segmentation overlays, and data were reviewed by a pathologist.
“All images, segmentation overlays, and data were reviewed by a pathologist.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDkk2, Wif1, and Ctnna3 can all negatively regulate Wnt activity.
“Dkk2, Wif1, and Ctnna3 can all negatively regulate Wnt activity (Hsieh et al., 1999; Busby et al., 2004; Gage et al., 2008), whereas Asb11 is important for maintaining progenitor cell activity in multiple cell types (Diks et al., 2006; Tee et al., 2012).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Hsieh et al., 1999
Not checked in the free run.
- cites Busby et al., 2004
Not checked in the free run.
- cites Gage et al., 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataCD45low and CD45high gates were defined using a nontransgenic animal as a control, and the same gates were transposed onto cells from PS2APP animals sorted on the same day in the same machine to ensure accuracy and consistency.
“CD45low and CD45high gates were defined using a nontransgenic animal as a control to identify microglia in their normal state (CD45low). The same gates were transposed onto cells from PS2APP animals sorted on the same day in the same machine to ensure accuracy and consistency in determining percentages of CD45low and CD45high populations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenTwo sections per animal were stained, with all cohorts stained and analyzed simultaneously.
“Two sections per animal were stained, with all cohorts stained and analyzed simultaneously.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataTrem2-dependent microglial proliferation and activation attenuate the toxic effects of Aβ toward neurons, i.e., the DAM state is mainly protective.
“Collectively, our data indicate that Trem2-dependent microglial proliferation and activation attenuate the toxic effects of Aβ toward neurons (i.e., the DAM state is mainly protective)”
Quote in the paperSubstantial claim- Rests on an assumption: The effects of Trem2 deletion in PS2APP mice are mediated specifically by microglial Trem2 rather than by other Trem2-expressing myeloid cells or non-myeloid cells.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenImaging and analysis for two-photon microscopy were performed under blinded conditions.
“Imaging and analysis were performed under blinded conditions.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationTranscriptional profiling studies have defined a disease/damage-associated microglial activation state that is commonly observed in the brains of neurodegeneration models.
“Transcriptional profiling studies have defined a disease/damage-associated microglial (DAM) activation state that is commonly observed in the brains of neurodegeneration models (Deczkowska et al., 2018; Friedman et al., 2018).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Deczkowska et al., 2018
Not checked in the free run.
- cites Friedman et al., 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAnimal pairs, including one PS2APP;Trem2wt and one PS2APP;Trem2ko animal, were generally processed together from perfusion through sorting.
“Generally, animal pairs, including one PS2APP;Trem2wt and one PS2APP;Trem2ko animal, were processed together from perfusion through sorting.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductreasoningThe 6-7 month cohort of male and female mice was purposely analyzed separately to determine the effects of Trem2 deficiency in each sex since female mice have accelerated amyloid pathology compared with males, and to avoid confounding by age-dependent differences in pathology between males and females.
“The 6–7 month cohort of male and female mice was purposely analyzed separately to determine the effects of Trem2 deficiency in each sex since female mice have accelerated amyloid pathology compared with males, and we did not want an analysis of interactions between sex and Trem2 genotype to be confounded by the age-dependent differences in pathology between males and females.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn the PS19 model, Trem2 deletion had a protective effect, preventing tau-driven synaptic loss and atrophy in the hippocampus and entorhinal cortex, respectively.
“In contrast, in the PS19 model (Yoshiyama et al., 2007), Trem2 deletion had a protective effect, preventing tau-driven synaptic loss and atrophy in the hippocampus and entorhinal cortex, respectively (Leyns et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Leyns et al., 2017
Not checked in the free run.
May combine two claims.
Study design and conductown dataAs a control, PS2APP;Bace1ko hippocampal TBS homogenate supernatant showed minimal OC antibody detection but substantial 6E10 signal, consistent with the ability of 6E10 to detect both soluble APP and Aβ peptides.
“As a control, we spotted hippocampal TBS homogenate supernatant from a PS2APP;Bace1ko animal (Meilandt et al., 2019), in which soluble APP is still produced by α-cleavage while β-cleavage and thus Aβ production are prevented, and demonstrated that the OC antibody had minimal detection, whereas 6E10 still had substantial signal (compare # symbols in Fig. 5C,F and dotted lines in Fig. 5D,G from a PS”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Meilandt et al., 2019
Not checked in the free run.
May combine two claims.
InterpretationcitationThe elevated Aβ42:Aβ40 ratio in Trem2-deficient brains may increase plaque seeding at younger ages while reducing the incorporation and compaction of Aβ into existing plaques at older ages.
“Together with our observation that total amyloid plaque is reduced in PS2APP;Trem2ko brains at later ages (Fig. 3A), these results suggest that the elevated Aβ42:Aβ40 ratio in Trem2-deficient brains may increase plaque seeding at younger ages (since Aβ42 is more prone to aggregate and deposit than Aβ40) (Klein, 2002) while reducing the incorporation and compaction of Aβ into existing plaques at”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Klein, 2002
Not checked in the free run.
- cites Condello et al., 2015
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe authors' results are reminiscent of a recent study of APPPS1 mice, which showed that Trem2 deletion produced increased seeding of amyloid plaques at early ages but slower rates of amyloid plaque accumulation at later ages.
“Overall, our results are reminiscent of a recent study of APPPS1 mice, which showed that Trem2 deletion produced increased seeding of amyloid plaques at early ages but slower rates of amyloid plaque accumulation at later ages (Parhizkar et al., 2019).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Parhizkar et al., 2019
Not checked in the free run.
May combine two claims.
Interpretationown dataMicroglial Apoe expression is induced by Aβ-driven neuropathology in a largely Trem2-independent manner, and Trem2-deficient microglia accumulate disproportionately large amounts of ApoE compared with normal PS2APP microglia.
“Together, our evidence indicates that microglial Apoe expression is induced by Aβ-driven neuropathology in a largely Trem2-independent manner, and that Trem2-deficient microglia accumulate disproportionately large amounts of ApoE compared with the smaller ApoE puncta observed in normal PS2APP microglia (Fig. 6C).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningTrem2 may both restrict the initial seeding of plaques and promote sequestration and compaction of Aβ into existing plaques.
“Thus, Trem2 may both restrict the initial seeding of plaques and promote sequestration and compaction of Aβ into existing plaques.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe form rather than the amount of plaque correlates with neuronal damage, and sufficient microgliosis occurs in PS2APP;Trem2het mice to enable plaque compaction and neuroprotection.
“The intermediate effect of Trem2 heterozygosity on microglial clustering around plaque (Figs. 1A, 7B) and Campbell-Switzer plaque staining (Fig. 3A), but not on plaque diffuseness (Fig. 4B), Aβ42:Aβ40 ratio (Fig. 5A), or neuritic dystrophy (Figs. 7C,D, 8A), suggested that the form rather than the amount of plaque correlates with neuronal damage, and that sufficient microgliosis occurs in PS2APP;T”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationAβ42 oligomers are commonly understood to be the more toxic form of Aβ.
“The elevated Aβ42:Aβ40 ratio and fibrillar Aβ oligomers in PS2APP;Trem2ko brains would seem to be detrimental for neuronal health since Aβ42 oligomers are commonly understood to be the more toxic form of Aβ (Klein, 2002; Haass and Selkoe, 2007).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Klein, 2002
Not checked in the free run.
- cites Haass and Selkoe, 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationApoe is one of the most highly induced genes in mouse microglia in response to neurodegenerative stimuli.
“Apoe is one of the most highly induced genes in mouse microglia in response to neurodegenerative stimuli (Deczkowska et al., 2018).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Deczkowska et al., 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationNfL measured in CSF or plasma has recently emerged as a potential biomarker of neurodegeneration in human patients and in mouse disease models.
“NfL measured in the CSF or plasma has recently emerged as a potential biomarker of neurodegeneration in human patients and in mouse disease models (Bacioglu et al., 2016; Khalil et al., 2018).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Bacioglu et al., 2016
Not checked in the free run.
- cites Khalil et al., 2018
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe authors were blinded to Trem2 genotype during plaque morphology assessment.
“Although we were blinded to Trem2 genotype, there was an obvious difference in plaque appearance between PS2APP;Trem2wt and PS2APP;Trem2ko brains, with X-34+ structures in PS2APP;Trem2ko brains looking more splayed and less compact (Fig. 4A), similar to descriptions of Trem2-dependent plaque alterations in other β-amyloid models (Wang et al., 2016; Yuan et al., 2016).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningAlternatively, the increased abundance of fibrillar Aβ oligomers in the TBS-soluble fraction could result from reduced incorporation into highly condensed plaques in brains with Trem2-deficient microglia.
“Alternatively, the increased abundance of fibrillar Aβ oligomers in the TBS-soluble fraction could result from reduced incorporation into highly condensed plaques in brains with Trem2-deficient microglia.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationElevated PET signal for ligands of the neuroinflammation marker TSPO have predicted better cognitive measures and slower AD progression in mice with β-amyloid pathology and human patients, respectively.
“elevated PET signal for ligands of the “neuroinflammation marker” TSPO have predicted better cognitive measures and slower AD progression in mice with β-amyloid pathology and human patients, respectively (Hamelin et al., 2016; Focke et al., 2019).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Hamelin et al., 2016
Not checked in the free run.
- cites Focke et al., 2019
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationReduced synaptic density, particularly near plaque, is a feature of AD tissues and β-amyloid mouse models.
“another feature of neuronal pathology observed in AD tissues and β-amyloid mouse models, reduced synaptic density, particularly near plaque (Spires and Hyman, 2004; Tsai et al., 2004; Spires et al., 2005)”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Spires and Hyman, 2004
Not checked in the free run.
- cites Tsai et al., 2004
Not checked in the free run.
- cites Spires et al., 2005
Not checked in the free run.
May combine two claims.
InterpretationcitationTrem2-dependent microglial activity may both restrain the formation/seeding of plaques at an early stage of pathology, conceivably through uptake and degradation of soluble Aβ species, but also enhance the sequestration of Aβ into existing plaque structures, particularly at later stages of pathology.
“Together with a recent similar report (Parhizkar et al., 2019), these results suggest that Trem2-dependent microglial activity may both restrain the formation/seeding of plaques at an early stage of pathology, conceivably through uptake and degradation of soluble Aβ species, but also enhance the sequestration of Aβ into existing plaque structures, particularly at later stages of pathology.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Parhizkar et al., 2019
Not checked in the free run.
May combine two claims.
Premisecitationβ-amyloid pathology accelerates the accumulation of tau pathology or enhances its spreading in humans and mice.
“Evidence in humans and mice supports the mechanistic model that β-amyloid pathology accelerates the accumulation of tau pathology or enhances its spreading (Pooler et al., 2015; He et al., 2018; Jack et al., 2018; Jacobs et al., 2018)”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Pooler et al., 2015
Not checked in the free run.
- cites He et al., 2018
Not checked in the free run.
- cites Jack et al., 2018
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe reduction of plaque accumulation activity in PS2APP;Trem2ko brains may underlie the elevated levels of fibrillar oligomeric Aβ detected in the soluble fraction, which may in turn be a source of increased neuronal injury in these animals.
“The reduction of this plaque accumulation activity in PS2APP;Trem2ko brains may underlie the elevated levels of fibrillar oligomeric Aβ we detected in the soluble fraction, which may in turn be a source of increased neuronal injury in these animals.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The effects of Trem2 deletion in PS2APP mice are mediated specifically by microglial Trem2 rather than by other Trem2-expressing myeloid cells or non-myeloid cells.
“TREM2 is an Alzheimer's disease (AD) risk gene expressed in microglia.”
The paper relies on this without support.
The Trem2tm1(KOMP)Vlcg allele completely abolishes Trem2 function in PS2APP;Trem2ko mice.
“The Trem2tm1(KOMP)Vlcg null allele (C57BL/6N background) was crossed into the PS2APP model (C57BL/6J background).”
The paper relies on this without support.
Amber core amyloid staining represents a mature form of highly condensed plaque.
“At this age, the Campbell-Switzer stain also revealed a distinctive pattern of “amber core” amyloid staining in PS2APP brains (Fig. 3C), thought to represent a mature form of highly condensed plaque.”
The paper relies on this without support.
Cognitive decline correlates better with tau pathology and synapse loss than with brain amyloid detection.
“helps explain why cognitive decline correlates better with tau pathology and synapse loss than with brain amyloid detection.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AD progression is better correlated with tau pathology, neuronal degeneration, Aβ spreading, and synapse loss than Aβ detection alone.
“AD progression is better correlated with tau pathology, neuronal degeneration, Aβ spreading and synapse loss, rather than Aβ detection alone [222]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [222]
The Discussion (page not provided) says cognitive decline correlates better with tau pathology and synapse loss than with brain amyloid detection, and proposes neuronal-degeneration biomarkers as more informative indicators. It discusses the spreading of tau pathology, not Aβ spreading; that part of the claim is unsupported. (LLM, conf=0.87)
Experimental — accuracy not yet measuredThe reduced MOAB2+ plaque sizes may be a result of reduced oligomeric Aβ compaction.
“which may be a result of reduced oligomeric Aβ compaction as described previously in another amyloidogenic mouse model. 62”
From PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology (2025) · cites this paper as [62]
The Results section (page not available) suggests that Trem2 deficiency may reduce the incorporation and compaction of Aβ into existing plaques in PS2APP mice. The Discussion also links reduced compact-plaque accumulation with elevated soluble fibrillar Aβ oligomers. The paper does not examine MOAB2+ plaque sizes or specifically show that reduced compaction of oligomeric Aβ causes smaller plaques. (LLM, conf=0.83)
Experimental — accuracy not yet measuredThe dichotomy of immune effects on amyloid and tau has been demonstrated in multiple models of Trem2 and Tyrobp.
“More recently, this dichotomy has been elegantly demonstrated in multiple models of Trem2 and Tyrobp [49–51, 55–59].”
From Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways (2022) · cites this paper as [57]
The Introduction (page unavailable) describes differing effects of Trem2 deletion on amyloid plaques and tau pathology across several mouse models, supporting the Trem2 portion of the claim. This paper studies a PS2APP Trem2-deletion model; the passages do not establish the claim about Tyrobp models. (LLM, conf=0.84)
Experimental — accuracy not yet measuredIn studies of Trem2 deficiency, differences were dependent on early versus later disease stages.
“A similar interpretation could be developed from the studies of Trem2 deficiency, as differences were dependent on early versus later disease stages.50,51,57,58”
From Microglial <i>INPP5D</i> limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [57]
Microglia can have differential effects on Alzheimer's disease pathology depending on the disease stage.
“These studies have led to the notion that microglia can have differential effects on AD pathology depending on the disease stage.”
From The effect of Abi3 locus deletion on the progression of Alzheimer’s disease-related pathologies (2023) · cites this paper as [8]
Earlier studies on other microglial AD risk genes reported opposing effects on AD-related pathologies using various animal models at different ages.
“Earlier studies on other microglial AD risk genes reported opposing effects on AD-related pathologies using various animal models at different ages (8–14).”
From The effect of Abi3 locus deletion on the progression of Alzheimer’s disease-related pathologies (2023) · cites this paper as [8]
Deletion of Trem2 altered amyloid pathology in opposite directions depending on the stage of the disease.
“Functional studies demonstrated that deletion of Trem2 altered amyloid pathology in opposite directions depending on the stage of the disease (20–23), but overexpression of TREM2 reduced the pathology in transgenic mouse models of amyloidosis (24).”
From Deletion of <i>Abi3</i> gene locus exacerbates neuropathological features of Alzheimer’s disease in a mouse model of Aβ amyloidosis (2021) · cites this paper as [23]
Conflicting results have been reported regarding amyloid plaque deposition and the effect of TREM2 loss, suggesting that the effect of TREM2 on Ab deposition may be dependent on age, sex, and the model utilized.
“Conflicting results have been reported regarding amyloid plaque deposition and the effect of TREM2 loss [7,8,9,10,11], suggesting that the effect of TREM2 on Ab deposition may be dependent on age, sex, and the model utilized.”
From TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo (2023) · cites this paper as [9]
Manipulation of Trem2, Tyrobp, Cx3cl1/Cx3cr1, IL1β, and IFN-γ have opposing effects on amyloid and tau pathologies.
“Indeed, manipulation of expression of Trem2, Tyrobp, Cx3cl1/Cx3cr1, IL1β, and IFN-γ have all been shown to have opposing effects on amyloid and tau pathologies [49–51, 55–65].”
From Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways (2022) · cites this paper as [57]
Impaired or absent Trem2 function attenuates the microglial response to amyloid pathology by regulating microglial number around plaques, regulating microglial activity, and restricting neuritic damage.
“Recent important studies have also shown that impaired/absent Trem2 function attenuates the microglial response to amyloid pathology by regulating microglial number around plaques, regulating microglial activity, and restricting neuritic damage (37,61,84–87,95–99).”
From <i>Trem2</i> promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [98]
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1× · see citing works
“Normalization was based on the nRPKM method, which is proportional to size factor normalization of DESeq (Love et al., 2014).”
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · cited 1× · see citing works
“Moreover, many have proposed that chronic microglial activation is a key damaging agent that contributes to the neurotoxic environment in AD (Heneka et al., 2015; Park et al., 2018).”
Backgroundvoom: precision weights unlock linear model analysis tools for RNA-seq read counts
Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155 · cited 1× · see citing works
“Differential expression was performed using voom limma (Law et al., 2014).”
MethodA Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493 · cited 12× · see citing works
“The entirety of these changes is approximately equivalent to the so-called DAM (Keren-Shaul et al., 2017) or MgND (Krasemann et al.”
BackgroundMethodResultInfluentialSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 2× · see citing works
“Axonal dystrophy, dendritic spine loss, and CSF NfL detection are exacerbated in PS2APP;Trem2 ko mice The elevated A 42:A 40 ratio and fibrillar A oligomers in PS2APP;Trem2 ko brains would seem to be detrimental for neuronal health since A 42 oligomers are commonly understood to be the more toxic form of A (Klein, 200…”
BackgroundComplement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 2× · see citing works
“…underscored that the Trem2-dependent microglial activation around plaque is protective for neurons and is distinct from microglia-mediated, complement-mediated activities that contribute to synapse loss in -amyloid models (Fonseca et al., 2004; Hong et al., 2016; Shi et al., 2017; Wu et al., 2019).”
Background<i>TREM2</i> Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 2× · see citing works
“Since the discovery of TREM2 (triggering receptor expressed on myeloid cells 2) variants as genetic risk factors for Alzheimer’s disease (AD) (Guerreiro et al., 2013; Jonsson et al., 2013), TREM2 biology has become a focal point in research efforts to better understand how the innate immune system impacts AD and other…”
BackgroundKrasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979 · cited 6× · see citing works
“Although two groups have reported reductions in microglial Apoe expression in the APPPS1 model when Trem2 is deleted (Krasemann et al., 2017; Parhizkar et al., 2019), this does not appear to be a typical feature of Trem2 deficiency in -amyloidosis models since previous analyses in the 5xFAD model…”
BackgroundMethodResultInfluentialMi, H., Muruganujan, A., Ebert, D., Huang, X., & Thomas, P. D. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1038 · Cited by 2,950 · cited 2× · see citing works
“1 (Mi et al., 2019) at the website (http:// pantherdb.”
MethodInfluentialVariant of <i>TREM2</i> Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 2× · see citing works
“Since the discovery of TREM2 (triggering receptor expressed on myeloid cells 2) variants as genetic risk factors for Alzheimer’s disease (AD) (Guerreiro et al., 2013; Jonsson et al., 2013), TREM2 biology has become a focal point in research efforts to better understand how the innate immune system impacts AD and other…”
BackgroundSynapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · cited 1× · see citing works
“In contrast, in the PS19 model (Yoshiyama et al., 2007), Trem2 deletion had a protective effect, preventing tau-driven synaptic loss and atrophy in the hippocampus and entorhinal cortex, respectively (Leyns et al., 2017).”
ResultA practical guide to evaluating colocalization in biological microscopy.
Dunn, K., Kamocka, M., & McDonald, J. (2011) · American Journal of Physiology - Cell Physiology · doi:10.1152/ajpcell.00462.2010 · Cited by 1,998 · cited 2× · see citing works
“To determine colocalization of ApoE and Iba1 staining, or methoxy-X04 and Iba1 staining, we calculated the Mander’s colocalization coefficients using the ImageJ plugin JACoP, as described previously (Dunn et al., 2011).”
MethodNeurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988 · cited 1× · see citing works
“NfL measured in the CSF or plasma has recently emerged as a potential biomarker of neurodegeneration in human patients and in mouse disease models (Bacioglu et al., 2016; Khalil et al., 2018).”
BackgroundMicroglia in Alzheimer’s disease
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935 · see citing works
Self-citationTREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736 · cited 10× · see citing works
“Plaque load is reduced in aged PS2APP;Trem2 ko mice In the 5xFAD mouse model, plaque load was reportedly unchanged in 4 month Trem2 ko mice but increased in 8 month Trem2 ko hippocampus (Wang et al., 2015, 2016; Yuan et al., 2016).”
BackgroundMethodResultInfluentialDisease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
Deczkowska, A., Keren-Shaul, H., Weiner, A., Colonna, M., Schwartz, M., & Amit, I. (2018) · Cell · doi:10.1016/j.cell.2018.05.003 · Cited by 1,474 · cited 2× · see citing works
“Apoe is one of the most highly induced genes in mouse microglia in response to neurodegenerative stimuli (Deczkowska et al., 2018).”
BackgroundTREM2 Maintains Microglial Metabolic Fitness in Alzheimer’s Disease
Ulland, T. K., Song, W. M., Huang, S. C.-C., Ulrich, J. D., Sergushichev, A., Beatty, W. L., Loboda, A. A., Zhou, Y., Cairns, N. J., Kambal, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.023 · Cited by 1,263 · cited 2× · see citing works
“, 2003), AKT and mTOR signaling (Ulland et al., 2017), attenuation of proinflammatory macrophage activation (Turnbull et al.”
BackgroundYeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C., & Sheng, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.015 · Cited by 943 · cited 1× · see citing works
“…fraction of PS2APP;Trem2 ko brains could reflect direct deficits in the Trem2-mediated binding and clearance of oligomeric A 42 by microglia (Yeh et al., 2016; Lessard et al., 2018; Zhao et al., 2018), it could also reflect enhanced clearance of A 40 through other means, such as vascular…”
BackgroundSelf-citationTREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840 · cited 7× · see citing works
“Plaque load is reduced in aged PS2APP;Trem2 ko mice In the 5xFAD mouse model, plaque load was reportedly unchanged in 4 month Trem2 ko mice but increased in 8 month Trem2 ko hippocampus (Wang et al., 2015, 2016; Yuan et al., 2016).”
BackgroundResultInfluentialYuan, P., Condello, C., Keene, C. D., Wang, Y., Bird, T. D., Paul, S. M., Luo, W., Colonna, M., Baddeley, D., & Grutzendler, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.003 · Cited by 817 · see citing works
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Zhao, Y., Wu, X., Li, X., Jiang, L.-L., Gui, X., Liu, Y., Sun, Y., Zhu, B., Piña-Crespo, J. C., Zhang, M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.031 · Cited by 763 · cited 1× · see citing works
“…fraction of PS2APP;Trem2 ko brains could reflect direct deficits in the Trem2-mediated binding and clearance of oligomeric A 42 by microglia (Yeh et al., 2016; Lessard et al., 2018; Zhao et al., 2018), it could also reflect enhanced clearance of A 40 through other means, such as vascular efflux.”
BackgroundA new secreted protein that binds to Wnt proteins and inhibits their activites
Hsieh, J.-C., Kodjabachian, L., Rebbert, M. L., Rattner, A., Smallwood, P. M., Samos, C. H., Nusse, R., Dawid, I. B., & Nathans, J. (1999) · Nature · doi:10.1038/18899 · Cited by 750 · cited 1× · see citing works
“Dkk2, Wif1, and Ctnna3 can all negatively regulate Wnt activity (Hsieh et al., 1999; Busby et al., 2004; Gage et al., 2008), whereas Asb11 is important for maintaining progenitor cell activity in multiple cell types (Diks et al., 2006; Tee et al., 2012).”
BackgroundTREM2 — a key player in microglial biology and Alzheimer disease
Ulland, T. K., & Colonna, M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0072-1 · Cited by 735 · cited 2× · see citing works
“…compaction of A into dense plaques is a protective microglial activity, limiting the exposure of neurons to toxic A species. tive or detrimental functions in mouse models of AD-related neuropathology has been rather unclear (Gratuze et al., 2018; Hansen et al., 2018; Ulland and Colonna, 2018).”
BackgroundHyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
Andorfer, C., Kress, Y., Espinoza, M., De Silva, R., Tucker, K. L., Barde, Y., Duff, K., & Davies, P. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01879.x · Cited by 722 · cited 1× · see citing works
“In the hTau model (Andorfer et al., 2003), Trem2 deletion increased the amounts of tau phosphorylation and aggregation detected (Bemiller et al., 2017).”
BackgroundMicroglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques
Condello, C., Yuan, P., Schain, A., & Grutzendler, J. (2015) · Nature Communications · doi:10.1038/ncomms7176 · Cited by 718 · cited 4× · see citing works
“3A), these results suggest that the elevated A 42: A 40 ratio in Trem2-deficient brains may increase plaque seeding at younger ages (since A 42 is more prone to aggregate and deposit than A 40) (Klein, 2002) while reducing the incorporation and compaction of A into existing plaques at older ages (since A 40 permeates…”
BackgroundInfluentialSpangenberg, E. E., Lee, R. J., Najafi, A. R., Rice, R. A., Elmore, M. R. P., Blurton-Jones, M., West, B. L., & Green, K. N. (2016) · Brain · doi:10.1093/brain/aww016 · Cited by 695 · cited 1× · see citing works
“In -amyloid models, the reduction in synapse number requires the presence of microglia since depleting the microglial cell population largely prevents loss of synaptic density (Olmos-Alonso et al., 2016; Spangenberg et al., 2016).”
BackgroundCutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688 · cited 2× · see citing works
“, 2017), attenuation of proinflammatory macrophage activation (Turnbull et al., 2006), chemotaxis (Mazaheri et al.”
BackgroundJay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142322 · Cited by 682 · cited 5× · see citing works
“Trem2 deletion in amyloidosis models has also been reported to either increase or decrease phosphorylation of the endogenous tau protein (Jay et al., 2015; Wang et al., 2016).”
BackgroundMethodResultInfluentialFriedman, B. A., Srinivasan, K., Ayalon, G., Meilandt, W. J., Lin, H., Huntley, M. A., Cao, Y., Lee, S.-H., Haddick, P. C. G., Ngu, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.066 · Cited by 662 · cited 5× · see citing works
“The majority of these transcripts showed upregulation in microglial expression profiles from the PS2APP model (Friedman et al., 2018) and other models of -amyloid pathology (Orre et al., 2014; Wang et al., 2015) compared with nontransgenic mice (Fig.”
BackgroundInfluentialSelf-citationHe, Z., Guo, J. L., McBride, J. D., Narasimhan, S., Kim, H., Changolkar, L., Zhang, B., Gathagan, R. J., Yue, C., Dengler, C., et al. (2018) · Nature Medicine · doi:10.1038/nm.4443 · Cited by 645 · see citing works
A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease
Park, J., Wetzel, I., Marriott, I., Dréau, D., D’Avanzo, C., Kim, D. Y., Tanzi, R. E., & Cho, H. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0175-4 · Cited by 644 · see citing works
Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593 · cited 2× · see citing works
“…underscored that the Trem2-dependent microglial activation around plaque is protective for neurons and is distinct from microglia-mediated, complement-mediated activities that contribute to synapse loss in -amyloid models (Fonseca et al., 2004; Hong et al., 2016; Shi et al., 2017; Wu et al., 2019).”
BackgroundFibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches
Tsai, J., Grutzendler, J., Duff, K., & Gan, W.-B. (2004) · Nature Neuroscience · doi:10.1038/nn1335 · Cited by 561 · cited 1× · see citing works
“Finally, we looked at whether another feature of neuronal pathology observed in AD tissues and -amyloid mouse models, reduced synaptic density, particularly near plaque (Spires and Hyman, 2004; Tsai et al., 2004; Spires et al., 2005), was altered in Trem2-deficient mice.”
BackgroundLoss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deussing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0296-9 · Cited by 555 · cited 14× · see citing works
“Parhizkar et al. (2019) also reported that colocalization of ApoE with Iba1 microglia was reduced in Trem2-deficient mice.”
BackgroundMethodResultInfluentialSpires, T. L., Meyer-Luehmann, M., Stern, E. A., McLean, P. J., Skoch, J., Nguyen, P. T., Bacskai, B. J., & Hyman, B. T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1879-05.2005 · Cited by 550 · cited 1× · see citing works
“Finally, we looked at whether another feature of neuronal pathology observed in AD tissues and -amyloid mouse models, reduced synaptic density, particularly near plaque (Spires and Hyman, 2004; Tsai et al., 2004; Spires et al., 2005), was altered in Trem2-deficient mice.”
BackgroundAβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets
Klein, W. L. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00050-5 · Cited by 541 · see citing works
Olmos-Alonso, A., Schetters, S. T. T., Sri, S., Askew, K., Mancuso, R., Vargas-Caballero, M., Holscher, C., Perry, V. H., & Gomez-Nicola, D. (2016) · Brain · doi:10.1093/brain/awv379 · Cited by 532 · cited 1× · see citing works
“In -amyloid models, the reduction in synapse number requires the presence of microglia since depleting the microglial cell population largely prevents loss of synaptic density (Olmos-Alonso et al., 2016; Spangenberg et al., 2016).”
BackgroundMicrobes and Alzheimer’s Disease
Itzhaki, R. F., Lathe, R., Balin, B. J., Ball, M. J., Bearer, E. L., Braak, H., Bullido, M. J., Carter, C., Clerici, M., Cosby, S. L., et al. (2016) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160152 · Cited by 532 · cited 2× · see citing works
“The weakness of correlation between plaque abundance and cognitive status in humans, along with several unsuccessful clinical trials aimed at preventing cognitive decline by reducing brain A levels, has led some to question the relevance of A in the etiology and progression of AD (Krstic and Knuesel, 2013; Morris et a…”
BackgroundTREM2 sustains microglial expansion during aging and response to demyelination
Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77983 · Cited by 525 · cited 1× · see citing works
“The acquisition of the DAM state is Trem2-dependent in mouse models of AD, amyotrophic lateral sclerosis, and demyelinating disease (Poliani et al., 2015; Wang et al., 2015; Keren-Shaul et al., 2017; Krasemann et al., 2017).”
BackgroundInconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease
Morris, G. P., Clark, I. A., & Vissel, B. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0135-5 · Cited by 522 · cited 2× · see citing works
“The weakness of correlation between plaque abundance and cognitive status in humans, along with several unsuccessful clinical trials aimed at preventing cognitive decline by reducing brain A levels, has led some to question the relevance of A in the etiology and progression of AD (Krstic and Knuesel, 2013; Morris et a…”
BackgroundHamelin, L., Lagarde, J., Dorothée, G., Leroy, C., Labit, M., Comley, R. A., de Souza, L. C., Corne, H., Dauphinot, L., Bertoux, M., et al. (2016) · Brain · doi:10.1093/brain/aww017 · Cited by 519 · cited 1× · see citing works
“…primarily beneficial in the context of AD pathology, elevated PET signal for ligands of the “neuroinflammation marker” TSPO have predicted better cognitive measures and slower AD progression in mice with -amyloid pathology and human patients, respectively (Hamelin et al., 2016; Focke et al., 2019).”
BackgroundLeyns, C. E. G., Ulrich, J. D., Finn, M. B., Stewart, F. R., Koscal, L. J., Remolina Serrano, J., Robinson, G. O., Anderson, E., Colonna, M., & Holtzman, D. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710311114 · Cited by 517 · cited 2× · see citing works
“, 2007), Trem2 deletion had a protective effect, preventing tau-driven synaptic loss and atrophy in the hippocampus and entorhinal cortex, respectively (Leyns et al., 2017).”
BackgroundResultNew insights into the role of TREM2 in Alzheimer’s disease
Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0298-9 · Cited by 489 · cited 2× · see citing works
“…compaction of A into dense plaques is a protective microglial activity, limiting the exposure of neurons to toxic A species. tive or detrimental functions in mouse models of AD-related neuropathology has been rather unclear (Gratuze et al., 2018; Hansen et al., 2018; Ulland and Colonna, 2018).”
BackgroundWu, T., Dejanovic, B., Gandham, V. D., Gogineni, A., Edmonds, R., Schauer, S., Srinivasan, K., Huntley, M. A., Wang, Y., Wang, T.-M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.060 · Cited by 466 · cited 1× · see citing works
“…underscored that the Trem2-dependent microglial activation around plaque is protective for neurons and is distinct from microglia-mediated, complement-mediated activities that contribute to synapse loss in -amyloid models (Fonseca et al., 2004; Hong et al., 2016; Shi et al., 2017; Wu et al., 2019).”
BackgroundSelf-citationBouchon, A., Hernández-Munain, C., Cella, M., & Colonna, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1111 · Cited by 460 · cited 1× · see citing works
“…described roles for Trem2 in osteoclast function (Cella et al., 2003; Paloneva et al., 2003), AKT and mTOR signaling (Ulland et al., 2017), attenuation of proinflammatory macrophage activation (Turnbull et al., 2006), chemotaxis (Mazaheri et al., 2017), and DAP12 signaling (Bouchon et al., 2001).”
BackgroundDisease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
Jay, T. R., Hirsch, A. M., Broihier, M. L., Miller, C. M., Neilson, L. E., Ransohoff, R. M., Lamb, B. T., & Landreth, G. E. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2110-16.2016 · Cited by 457 · see citing works
Longitudinal tau PET in ageing and Alzheimer’s disease
Jack, C. R., Wiste, H. J., Schwarz, C. G., Lowe, V. J., Senjem, M. L., Vemuri, P., Weigand, S. D., Therneau, T. M., Knopman, D. S., Gunter, J. L., et al. (2018) · Brain · doi:10.1093/brain/awy059 · Cited by 452 · cited 1× · see citing works
“…model that -amyloid pathology accelerates the accumulation of tau pathology or enhances its spreading (Pooler et al., 2015; He et al., 2018; Jack et al., 2018; Jacobs et al., 2018), and a new report indicates that this effect is further magnified in Trem2-deficient mice (Leyns et al.,…”
BackgroundTREM2, microglia, and neurodegenerative diseases
Yeh, F. L., Hansen, D. V., & Sheng, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.008 · Cited by 440 · cited 2× · see citing works
“…for Alzheimer’s disease (AD) (Guerreiro et al., 2013; Jonsson et al., 2013), TREM2 biology has become a focal point in research efforts to better understand how the innate immune system impacts AD and other neurodegenerative diseases (Jay et al., 2017b; Ulrich et al., 2017; Yeh et al., 2017).”
BackgroundSelf-citationBacioglu, M., Maia, L. F., Preische, O., Schelle, J., Apel, A., Kaeser, S. A., Schweighauser, M., Eninger, T., Lambert, M., Pilotto, A., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.018 · Cited by 435 · see citing works
TREM2 in Neurodegenerative Diseases
Jay, T. R., von Saucken, V. E., & Landreth, G. E. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0197-5 · Cited by 427 · cited 4× · see citing works
“…genes was consistent with the notion mentioned above that Wnt-related signaling was impaired and also corroborated reports from other -amyloid models that proliferation markers, such as Ki67 or BrdU, were observed less frequently in Trem2-deficient microglia (Wang et al., 2016; Jay et al., 2017a).”
BackgroundMethodResultInfluentialGMAP and GSNAP for Genomic Sequence Alignment: Enhancements to Speed, Accuracy, and Functionality
Wu, T. D., Reeder, J., Lawrence, M. F., Becker, G., & Brauer, M. J. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3578-9_15 · Cited by 419 · cited 1× · see citing works
“Remaining reads were aligned to the GRCm38 genome with GSNAP aligner (Wu et al., 2016), and reads overlapping each gene were quantified.”
MethodSelf-citationKlunk, W. E., Bacskai, B. J., Mathis, C. A., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., Debnath, M. L., Holt, D. P., Wang, Y., & Hyman, B. T. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.9.797 · Cited by 412 · cited 1× · see citing works
“At 24 h before brain collection, animals received intraperitoneal injections of methoxy-X04 (10 mg/kg) to label amyloid structures (Klunk et al., 2002).”
MethodGowrishankar, S., Yuan, P., Wu, Y., Schrag, M., Paradise, S., Grutzendler, J., De Camilli, P., & Ferguson, S. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510329112 · Cited by 406 · cited 2× · see citing works
“, 2003) by fluorescent costaining using methoxyX04 to label plaque, anti-Iba1 to label microglia, and anti-Lamp1 to label dystrophic axons (Gowrishankar et al., 2015) (Fig.”
BackgroundIsolation of glia from Alzheimer’s mice reveals inflammation and dysfunction
Orre, M., Kamphuis, W., Osborn, L. M., Jansen, A. H. P., Kooijman, L., Bossers, K., & Hol, E. M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.004 · Cited by 394 · cited 2× · see citing works
“The majority of these transcripts showed upregulation in microglial expression profiles from the PS2APP model (Friedman et al., 2018) and other models of -amyloid pathology (Orre et al., 2014; Wang et al., 2015) compared with nontransgenic mice (Fig.”
BackgroundTREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease
Griciuc, A., Patel, S., Federico, A. N., Choi, S. H., Innes, B. J., Oram, M. K., Cereghetti, G., McGinty, D., Anselmo, A., Sadreyev, R. I., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.06.010 · Cited by 378 · cited 8× · see citing works
“We also observed less induc- tion of the Proliferation module in Trem2 ko microglia expression profiles from the 5xFAD model (Griciuc et al., 2019) (Fig.”
BackgroundMethodResultInfluentialLoss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deußing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019) · doi:10.7892/boris.125653 · Cited by 352 · see citing works
TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury
Mazaheri, F., Snaidero, N., Kleinberger, G., Madore, C., Daria, A., Werner, G., Krasemann, S., Capell, A., Trümbach, D., Wurst, W., et al. (2017) · The EMBO Reports · doi:10.15252/embr.201743922 · Cited by 351 · cited 2× · see citing works
“…described roles for Trem2 in osteoclast function (Cella et al., 2003; Paloneva et al., 2003), AKT and mTOR signaling (Ulland et al., 2017), attenuation of proinflammatory macrophage activation (Turnbull et al., 2006), chemotaxis (Mazaheri et al., 2017), and DAP12 signaling (Bouchon et al., 2001).”
BackgroundAbsence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease
Fonseca, M. I., Zhou, J., Botto, M., & Tenner, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0901-04.2004 · Cited by 345 · cited 2× · see citing works
“…underscored that the Trem2-dependent microglial activation around plaque is protective for neurons and is distinct from microglia-mediated, complement-mediated activities that contribute to synapse loss in -amyloid models (Fonseca et al., 2004; Hong et al., 2016; Shi et al., 2017; Wu et al., 2019).”
BackgroundTomic, J. L., Pensalfini, A., Head, E., & Glabe, C. G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.024 · Cited by 336 · cited 1× · see citing works
“Using the conformation-specific OC antibody (Tomic et al., 2009), we detected significantly higher levels of soluble fibrillar A oligomers in the soluble fraction from PS2APP;Trem2 ko mice (Fig.”
BackgroundUntangling the brain’s neuroinflammatory and neurodegenerative transcriptional responses
Srinivasan, K., Friedman, B. A., Larson, J. L., Lauffer, B. E., Goldstein, L. D., Appling, L. L., Borneo, J., Poon, C., Ho, T., Cai, F., et al. (2016) · Nature Communications · doi:10.1038/ncomms11295 · Cited by 336 · cited 2× · see citing works
“Tissues were dissociated and cell suspensions prepared as described previously (Srinivasan et al., 2016).”
MethodSelf-citationTREM2 function impedes tau seeding in neuritic plaques
Leyns, C. E. G., Gratuze, M., Narasimhan, S., Jain, N., Koscal, L. J., Jiang, H., Manis, M., Colonna, M., Lee, V. M. Y., Ulrich, J. D., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0433-0 · Cited by 332 · cited 2× · see citing works
“…model that -amyloid pathology accelerates the accumulation of tau pathology or enhances its spreading (Pooler et al., 2015; He et al., 2018; Jack et al., 2018; Jacobs et al., 2018), and a new report indicates that this effect is further magnified in Trem2-deficient mice (Leyns et al., 2019).”
BackgroundKremen2 modulates Dickkopf2 activity during Wnt/lRP6 signaling
Mao, B., & Niehrs, C. (2003) · Gene · doi:10.1016/s0378-1119(02)01106-x · Cited by 325 · cited 2× · see citing works
“tivator of the pathway (Wu et al., 2000; Mao and Niehrs, 2003; Devotta et al., 2018) and since induction of regulators, including Wif1, can occur downstream of active -catenin as negative feedback (Diep et al.”
BackgroundElucidating the Role of TREM2 in Alzheimer’s Disease
Ulrich, J. D., Ulland, T. K., Colonna, M., & Holtzman, D. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.042 · Cited by 325 · cited 2× · see citing works
“…for Alzheimer’s disease (AD) (Guerreiro et al., 2013; Jonsson et al., 2013), TREM2 biology has become a focal point in research efforts to better understand how the innate immune system impacts AD and other neurodegenerative diseases (Jay et al., 2017b; Ulrich et al., 2017; Yeh et al., 2017).”
BackgroundDAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
Paloneva, J., Mandelin, J., Kiialainen, A., Böhling, T., Prudlo, J., Hakola, P., Haltia, M., Konttinen, Y. T., & Peltonen, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030027 · Cited by 318 · cited 2× · see citing works
“The Trem2-dependent genes identified in these processes may underlie described roles for Trem2 in osteoclast function (Cella et al., 2003; Paloneva et al., 2003), AKT and mTOR signaling (Ulland et al., 2017), attenuation of proinflammatory macrophage activation (Turnbull et al., 2006), chemotaxis…”
BackgroundTREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway
Zheng, H., Jia, L., Liu, C.-C., Rong, Z., Zhong, L., Yang, L., Chen, X.-F., Fryer, J. D., Wang, X., Zhang, Y.-W., et al. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2459-16.2017 · Cited by 317 · cited 2× · see citing works
“The reduced expression of Wnt-related signaling components and regulators in PS2APP;Trem2 ko microglia may be consistent with previous reports of coordinated signaling between Trem2 and -catenin pathways within microglia (Zheng et al., 2017; Zulfiqar and Tanriöver, 2017).”
ResultBemiller, S. M., McCray, T. J., Allan, K., Formica, S. V., Xu, G., Wilson, G., Kokiko-Cochran, O. N., Crish, S. D., Lasagna-Reeves, C. A., Ransohoff, R. M., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0216-6 · Cited by 299 · cited 1× · see citing works
“In the hTau model (Andorfer et al., 2003), Trem2 deletion increased the amounts of tau phosphorylation and aggregation detected (Bemiller et al., 2017).”
BackgroundJacobs, H. I. L., Hedden, T., Schultz, A. P., Sepulcre, J., Perea, R. D., Amariglio, R. E., Papp, K. V., Rentz, D. M., Sperling, R. A., & Johnson, K. A. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0070-z · Cited by 270 · cited 2× · see citing works
“…model that -amyloid pathology accelerates the accumulation of tau pathology or enhances its spreading (Pooler et al., 2015; He et al., 2018; Jack et al., 2018; Jacobs et al., 2018), and a new report indicates that this effect is further magnified in Trem2-deficient mice (Leyns et al., 2019).”
BackgroundImpaired Differentiation of Osteoclasts in TREM-2–deficient Individuals
Cella, M., Buonsanti, C., Strader, C., Kondo, T., Salmaggi, A., & Colonna, M. (2003) · Journal of Experimental Medicine · doi:10.1084/jem.20022220 · Cited by 256 · cited 1× · see citing works
“The Trem2-dependent genes identified in these processes may underlie described roles for Trem2 in osteoclast function (Cella et al., 2003; Paloneva et al., 2003), AKT and mTOR signaling (Ulland et al., 2017), attenuation of proinflammatory macrophage activation (Turnbull et al., 2006), chemotaxis…”
BackgroundApplication of Silver Degeneration Stains for Neurotoxicity Testing
Switzer, R. C. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800109 · Cited by 242 · cited 3× · see citing works
“Indeed, using the Campbell-Switzer silver stain to label amyloid plaque (Campbell et al., 1987; Switzer, 2000), we observed that plaque burden was increased in 6 –7 month PS2APP;Trem2 ko females, and trending upward but not reaching significance in 6 –7 month PS2APP;Trem2 ko males (Fig.”
Methodde Olmos, J. S., Beltramino, C. A., & Lorenzo, S. D. O. D. (1994) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(94)90033-7 · Cited by 237 · cited 2× · see citing works
“Silver stains for amyloid plaque (Campbell-Switzer stain) (Switzer et al., 1993) and neuronal damage/degeneration (amino cupric silver) or “disintegrative degeneration” stain (de Olmos et al., 1994) were also performed at NeuroScience Associates.”
MethodAmyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease
Pooler, A. M., Polydoro, M., Maury, E. A., Nicholls, S. B., Reddy, S. M., Wegmann, S., William, C., Saqran, L., Cagsal-Getkin, O., Pitstick, R., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0199-x · Cited by 236 · cited 2× · see citing works
“…in humans and mice supports the mechanistic model that -amyloid pathology accelerates the accumulation of tau pathology or enhances its spreading (Pooler et al., 2015; He et al., 2018; Jack et al., 2018; Jacobs et al., 2018), and a new report indicates that this effect is further magnified in…”
BackgroundYuan, P., Condello, C., Keene, C. D., Wang, Y., Bird, T. D., Paul, S. M., Luo, W., Colonna, M., Baddeley, D., & Grutzendler, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.016 · Cited by 219 · cited 6× · see citing works
“Plaque load is reduced in aged PS2APP;Trem2 ko mice In the 5xFAD mouse model, plaque load was reportedly unchanged in 4 month Trem2 ko mice but increased in 8 month Trem2 ko hippocampus (Wang et al., 2015, 2016; Yuan et al., 2016).”
BackgroundResultInfluentialMutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/β-catenin signalling
Wu, W., Glinka, A., Delius, H., & Niehrs, C. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00868-x · Cited by 183 · cited 2× · see citing works
“…Trem2 ko microglia, another possibility is that Wnt-related signaling was impaired since Dkk2 is also a context-dependent ac- tivator of the pathway (Wu et al., 2000; Mao and Niehrs, 2003; Devotta et al., 2018) and since induction of regulators, including Wif1, can occur downstream of active…”
BackgroundAnti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
Kim, J., Eltorai, A. E. M., Jiang, H., Liao, F., Verghese, P. B., Kim, J., Stewart, F. R., Basak, J. M., & Holtzman, D. M. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20121274 · Cited by 160 · cited 1× · see citing works
“The studies used different ApoE monoclonal antibodies that likely interact with distinct epitopes or configurations of ApoE (Kim et al., 2012) and whose binding may be differentially impacted by variations in staining procedure.”
BackgroundHigh‐affinity interactions and signal transduction between Aβ oligomers and TREM2
Lessard, C. B., Malnik, S. L., Zhou, Y., Ladd, T. B., Cruz, P. E., Ran, Y., Chakrabaty, P., Mahan, T. E., Holtzman, D. M., Ulrich, J. D., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809027 · Cited by 151 · cited 2× · see citing works
“While the elevated A 42:A 40 ratio we observed in the soluble fraction of PS2APP;Trem2 ko brains could reflect direct deficits in the Trem2-mediated binding and clearance of oligomeric A 42 by microglia (Yeh et al., 2016; Lessard et al., 2018; Zhao et al., 2018), it could also reflect enhanced clearance of A 40 throug…”
BackgroundGage, P. J., Qian, M., Wu, D., & Rosenberg, K. I. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.02.030 · Cited by 132 · cited 2× · see citing works
“Dkk2, Wif1, and Ctnna3 can all negatively regulate Wnt activity (Hsieh et al., 1999; Busby et al., 2004; Gage et al., 2008), whereas Asb11 is important for maintaining progenitor cell activity in multiple cell types (Diks et al.”
BackgroundLai, J.-P., Oseini, A. M., Moser, C. D., et al. (2010) · Hepatology · doi:10.1002/hep.23848 · Cited by 121 · cited 2× · see citing works
“2-2A, available at https:// doi.org/10.1523/JNEUROSCI.1871-19.2019.f2-2), with six positive factors in Wnt signaling showing reduced expression including Fzd9 (Karasawa et al., 2002), Sulf2 (Lai et al., 2010), Bambi (Lin et al., 2008), Ptk7 (Berger et al., 2017), and Aspm (Buchman et al., 2011) along with Dkk2 (Fig.”
BackgroundInfluentialWang, A., Das, P., Switzer, R. C., Golde, T. E., & Jankowsky, J. L. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5077-10.2011 · Cited by 118 · cited 3× · see citing works
“Immunohistochemical (IHC) stains for Iba1, CD68, and Gfap were performed at NeuroScience Associates as described previously (Wang et al., 2011), and CD68-stained sections were counterstained with Nissl (0.05% thionine/0.08 M acetate buffer, pH 4.5).”
MethodInfluentialNeuronal Structure is Altered by Amyloid Plaques
Spires‐Jones, T. L., & Hyman, B. T. (2004) · Reviews in the Neurosciences · doi:10.1515/revneuro.2004.15.4.267 · Cited by 107 · cited 1× · see citing works
“Finally, we looked at whether another feature of neuronal pathology observed in AD tissues and -amyloid mouse models, reduced synaptic density, particularly near plaque (Spires and Hyman, 2004; Tsai et al., 2004; Spires et al., 2005), was altered in Trem2-deficient mice.”
BackgroundFrizzled-9 Is Activated by Wnt-2 and Functions in Wnt/β-Catenin Signaling
Karasawa, T., Yokokura, H., Kitajewski, J., & Lombroso, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205658200 · Cited by 100 · cited 2× · see citing works
“2-2A, available at https:// doi.org/10.1523/JNEUROSCI.1871-19.2019.f2-2), with six positive factors in Wnt signaling showing reduced expression including Fzd9 (Karasawa et al., 2002), Sulf2 (Lai et al., 2010), Bambi (Lin et al., 2008), Ptk7 (Berger et al., 2017), and Aspm (Buchman et al., 2011) along with Dkk2 (Fig.”
BackgroundInfluentialASPM regulates Wnt signaling pathway activity in the developing brainPreprint
Buchman, J. J., Durak, O., & Tsai, L. (2011) · Genes & Development · doi:10.1101/gad.16830211 · Cited by 97 · cited 3× · see citing works
“2-2A, available at https:// doi.org/10.1523/JNEUROSCI.1871-19.2019.f2-2), with six positive factors in Wnt signaling showing reduced expression including Fzd9 (Karasawa et al., 2002), Sulf2 (Lai et al., 2010), Bambi (Lin et al., 2008), Ptk7 (Berger et al., 2017), and Aspm (Buchman et al., 2011) along with Dkk2 (Fig.”
BackgroundInfluentialDiep, D. B., Hoen, N., Backman, M., Machoň, O., & Krauss, S. J. K. (2004) · Developmental Brain Research · doi:10.1016/j.devbrainres.2004.09.008 · Cited by 96 · cited 2× · see citing works
“, 2018) and since induction of regulators, including Wif1, can occur downstream of active -catenin as negative feedback (Diep et al., 2004; Boerboom et al., 2006).”
BackgroundOzmen, L., Albientz, A., Czech, C., & Jacobsen, H. (2008) · Neurodegenerative Diseases · doi:10.1159/000170884 · Cited by 95 · cited 2× · see citing works
“By 4 months of age, the first deposits of -amyloid plaque are detected, with age-dependent plaque accumulation occurring faster in females than in males (Ozmen et al., 2009; Kallop et al., 2014).”
BackgroundPTK7 Faces the Wnt in Development and Disease
Berger, H., Wodarz, A., & Borchers, A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00031 · Cited by 91 · cited 3× · see citing works
“2-2A, available at https:// doi.org/10.1523/JNEUROSCI.1871-19.2019.f2-2), with six positive factors in Wnt signaling showing reduced expression including Fzd9 (Karasawa et al., 2002), Sulf2 (Lai et al., 2010), Bambi (Lin et al., 2008), Ptk7 (Berger et al., 2017), and Aspm (Buchman et al., 2011) along with Dkk2 (Fig.”
BackgroundInfluentialD'Amore, J. D., Kajdasz, S. T., McLellan, M. E., Bacskai, B. J., Stern, E. A., & Hyman, B. T. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.2.137 · Cited by 89 · cited 2× · see citing works
“First, we looked at neuritic dystrophy around plaque (D’Amore et al., 2003) by fluorescent costaining using methoxyX04 to label plaque, anti-Iba1 to label microglia, and anti-Lamp1 to label dystrophic axons (Gowrishankar et al.”
BackgroundLin, Z., Gao, C., Ning, Y., He, X., Wu, W., & Chen, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804039200 · Cited by 73 · cited 3× · see citing works
“2-2A, available at https:// doi.org/10.1523/JNEUROSCI.1871-19.2019.f2-2), with six positive factors in Wnt signaling showing reduced expression including Fzd9 (Karasawa et al., 2002), Sulf2 (Lai et al., 2010), Bambi (Lin et al., 2008), Ptk7 (Berger et al., 2017), and Aspm (Buchman et al., 2011) along with Dkk2 (Fig.”
BackgroundInfluentialBehavioral and transcriptomic analysis of Trem2-null mice: not all knockout mice are created equal
Kang, S. S., Kurti, A., Baker, K. E., Liu, C.-C., Colonna, M., Ulrich, J. D., Holtzman, D. M., Bu, G., & Fryer, J. D. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx366 · Cited by 62 · cited 1× · see citing works
“Applying cutoffs of 2-fold change and adjusted p value 0.05, we observed only 7 transcripts with increased abundance in PS2APP;Trem2 ko versus PS2APP;Trem2 wt microglia (excluding Treml1, an artifact of the KO cassette insertion) (Kang et al., 2018).”
MethodInfluentialBoerboom, D., White, L. D., Dalle, S., Courty, J., & Richards, J. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3493 · Cited by 58 · cited 1× · see citing works
“…was impaired since Dkk2 is also a context-dependent ac- tivator of the pathway (Wu et al., 2000; Mao and Niehrs, 2003; Devotta et al., 2018) and since induction of regulators, including Wif1, can occur downstream of active -catenin as negative feedback (Diep et al., 2004; Boerboom et al., 2006).”
BackgroundKallop, D. Y., Meilandt, W. J., Gogineni, A., Easley‐Neal, C., Wu, T. Z., Jubb, A. M., Yaylaoglu, M., Shamloo, M., Tessier‐Lavigne, M., Scearce-Levie, K. A., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4963-13.2014 · Cited by 52 · cited 3× · see citing works
“Quantification of CD68 or Iba1 staining and enlarged dark cluster areas was performed using morphometric-based methods as previously described (Le Pichon et al., 2013; Kallop et al., 2014).”
BackgroundMethodSelf-citationPichon, C. E. L., Domínguez, S. L., Solanoy, H. O., Ngu, H., Lewin‐Koh, N., Chen, M., Eastham‐Anderson, J., Watts, R. J., & Scearce-Levie, K. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062342 · Cited by 50 · cited 1× · see citing works
“Quantification of CD68 or Iba1 staining and enlarged dark cluster areas was performed using morphometric-based methods as previously described (Le Pichon et al., 2013; Kallop et al., 2014).”
MethodSelf-citationFocke, C., Blume, T., Zott, B., Shi, Y., Deußing, M., Peters, F., Schmidt, C., Kleinberger, G., Lindner, S., Gildehaus, F., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.217703 · Cited by 48 · cited 1× · see citing works
“…primarily beneficial in the context of AD pathology, elevated PET signal for ligands of the “neuroinflammation marker” TSPO have predicted better cognitive measures and slower AD progression in mice with -amyloid pathology and human patients, respectively (Hamelin et al., 2016; Focke et al., 2019).”
BackgroundBusby, V. L., Goossens, S., Nowotny, P., Hamilton, G., Smemo, S., Harold, D. H., Turic, D., Jehu, L., Myers, A., Womick, M., et al. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:2:133 · Cited by 46 · see citing works
Meilandt, W. J., Maloney, J. A., Imperio, J., Lalehzadeh, G., Earr, T., Crowell, S., Bainbridge, T. W., Lu, Y., Ernst, J. A., Fuji, R. N., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0553-5 · Cited by 45 · cited 2× · see citing works
“As a control, we spotted hippocampal TBS homogenate supernatant from a PS2APP;Bace1 ko animal (Meilandt et al., 2019), in which soluble APP is still produced by -cleavage while -cleavage and thus A production are prevented, and demonstrated that the OC antibody had minimal detection, whereas 6E10…”
MethodSelf-citationKrstic, D., & Knuesel, I. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-62 · Cited by 36 · cited 2× · see citing works
“The weakness of correlation between plaque abundance and cognitive status in humans, along with several unsuccessful clinical trials aimed at preventing cognitive decline by reducing brain A levels, has led some to question the relevance of A in the etiology and progression of AD (Krstic and Knuesel, 2013; Morris et a…”
BackgroundDevotta, A., Hong, C., & Saint‐Jeannet, J. (2018) · eLife · doi:10.7554/elife.34404 · Cited by 36 · cited 1× · see citing works
“…is that Wnt-related signaling was impaired since Dkk2 is also a context-dependent ac- tivator of the pathway (Wu et al., 2000; Mao and Niehrs, 2003; Devotta et al., 2018) and since induction of regulators, including Wif1, can occur downstream of active -catenin as negative feedback (Diep et al.,…”
BackgroundThe novel gene asb11: a regulator of the size of the neural progenitor compartment
Diks, S. H., Bink, R. J., van de Water, S., Joore, J., van Rooijen, C., Verbeek, F. J., den Hertog, J., Peppelenbosch, M. P., & Živković, D. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601081 · Cited by 34 · cited 1× · see citing works
“, 2008), whereas Asb11 is important for maintaining progenitor cell activity in multiple cell types (Diks et al., 2006; Tee et al., 2012).”
Backgroundasb11 Is a Regulator of Embryonic and Adult Regenerative Myogenesis
Tee, J.-M., da Silva, M. A. S., Rygiel, A. M., Muncan, V., Bink, R. J., BRINK, G. R. V. D., van Tijn, P., Živković, D., Kodach, L. L., Guardavaccaro, D., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0123 · Cited by 16 · cited 2× · see citing works
“, 2008), whereas Asb11 is important for maintaining progenitor cell activity in multiple cell types (Diks et al., 2006; Tee et al., 2012).”
Backgroundβ-Catenin Pathway Is Involved in TREM2-Mediated Microglial Survival
Zulfiqar, S., & Tanriöver, G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1087-17.2017 · Cited by 5 · cited 2× · see citing works
“The reduced expression of Wnt-related signaling components and regulators in PS2APP;Trem2 ko microglia may be consistent with previous reports of coordinated signaling between Trem2 and -catenin pathways within microglia (Zheng et al., 2017; Zulfiqar and Tanriöver, 2017).”
Result
Flagged first, then by citations
Research works printed but not linked: 1
- Campbell, 1987, Alzheimer's plaques and tangles: a controlled and enhanced silver staining method, Soc Neuroscience Abstr, 13, 678
Cited by
Sorted by citations
The Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
Deczkowska, A., Weiner, A., & Amit, I. (2020) · Cell · doi:10.1016/j.cell.2020.05.003 · Cited by 648 · see citing works
Microglia regulation of synaptic plasticity and learning and memory
Zhou, M., Cornell, J., Salinas, S., & Huang, H.-Y. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.322423 · Cited by 548 · see citing works
Dejanovic, B., Wu, T., Tsai, M.-C., Graykowski, D., Gandham, V. D., Rose, C. M., Bakalarski, C. E., Ngu, H., Wang, Y., Pandey, S., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00281-1 · Cited by 341 · see citing works
Self-citationTrem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology
Lee, S.-H., Meilandt, W. J., Xie, L., Gandham, V. D., Ngu, H., Barck, K. H., Rezzonico, M. G., Imperio, J., Lalehzadeh, G., Huntley, M. A., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.02.010 · Cited by 300 · see citing works
Self-citationSengupta, U., & Kayed, R. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102270 · Cited by 303 · see citing works
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293 · see citing works
“Exploring TREM2: modulating microglial activity as a therapeutic strategy for AD Although TREM2-dependent activities may not significantly reduce amyloid plaque load in mouse models, they can promote plaque compaction and alleviate plaque-associated neuritic pathology (Ulrich et al., 2014; Wang et al., 2016; Meilandt…”
Backgroundvan Lengerich, B., Zhan, L., Xia, D., Chan, D., Joy, D., Park, J. I., Tatarakis, D., Calvert, M., Hummel, S., Lianoglou, S., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01240-0 · Cited by 233 · see citing works
Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease
Lewcock, J. W., Schlepckow, K., Di Paolo, G., Tahirovic, S., Monroe, K. M., & Haass, C. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.029 · Cited by 221 · see citing works
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 216 · see citing works
“Neuroprotective roles Microglia encircle Aβ plaques to prevent further growth and dissemination into the parenchyma [63], reducing damage to local neurites [295] Microglia may contribute to the phagocytic and enzymatic clearance of the Aβ plaque deposits [82] TREM2 expressed by damage-associated microglia is thought t…”
BackgroundLiu, W., Taso, O., Wang, R., Bayram, S., Graham, A. C., Garcia-Reitboeck, P., Mallach, A., Andrews, W. D., Piers, T. M., Botia, J. A., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa209 · Cited by 214 · see citing works
TREM2 dependent and independent functions of microglia in Alzheimer’s disease
Hou, J., Chen, Y., Grajales-Reyes, G., & Colonna, M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00588-y · Cited by 191 · see citing works
Morenas‐Rodríguez, E., Li, Y., Nuscher, B., Franzmeier, N., Xiong, C., Suárez‐Calvet, M., Fagan, A. M., Schultz, S., Gordon, B. A., Benzinger, T. L. S., et al. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00027-8 · Cited by 177 · see citing works
Targeting synapse function and loss for treatment of neurodegenerative diseases
Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 168 · see citing works
“Concordantly, deficiency of TREM2 function exacerbates neuritic dystrophy and neuronal damage 239 .”
Self-citationExploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine
Lynch, M. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.868448 · Cited by 146 · see citing works
“Consistently, TREM2ko in APP/PS1 mice increased plaque load in 6–7-month-old female mice but no changes were observed in male mice (Meilandt et al., 2020).”
BackgroundEwers, M., Biechele, G., Suárez‐Calvet, M., Sacher, C., Blume, T., Morenas‐Rodriguez, E., Deming, Y., Piccio, L., Cruchaga, C., Kleinberger, G., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012308 · Cited by 133 · see citing works
“The current study is limited with regard to range of AD disease severity, but effects of microglia activation may vary by disease stage as suggested by results from transgenic mice (Jay et al, 2017; Parhizkar et al, 2019; Meilandt et al, 2020) and clinical trials in humans (Leoutsakos et al, 2012).”
Zhao, P., Xu, Y., Jiang, L., Fan, X., Li, L., Li, X., Arase, H., Zhao, Y., Cao, W., Zheng, H., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq0095 · Cited by 141 · see citing works
“Because DAM is specialized microglia that phagocytes apoptotic neurons, which matches with the considerable roles played by TREM2 in synaptic pruning (69), DAM is not necessarily detrimental because it is a natural response of microglia to resolve the neurotoxic compounds generated (18, 20, 72).”
BackgroundTransgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Sanchez-Varo, R. M., Mejias‐Ortega, M., Fernandez-Valenzuela, J. J., Nuñez‐Diaz, C., Cáceres-Palomo, L., Vegas‐Gomez, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., García‐León, J. A., Moreno‐González, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 130 · see citing works
Shi, Q., Chang, C., Saliba, A., & Bhat, M. A. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2427-21.2022 · Cited by 134 · see citing works
TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease
Li, Y., Xu, H., Wang, H., Yang, K., Luan, J., & Wang, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115218 · Cited by 128 · see citing works
Long, H., Simmons, A., Mayorga, A. J., Burgess, B., Nguyen, T., Budda, B., Rychkova, A., Rhinn, H., Tassi, I., Ward, M. E., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01599-1 · Cited by 143 · see citing works
“TREM2 knockout has been reported to produce variable effects on Aβ load depending on the mouse model and disease stage [15, 24, 26, 27] but consistently results in increased neuritic dystrophy [23, 27, 28].”
BackgroundGut microbiota–driven brain Aβ amyloidosis in mice requires microglia
Dodiya, H. B., Lutz, H. L., Weigle, I. Q., Patel, P., Michalkiewicz, J., Roman-Santiago, C. J., Zhang, C. M., Liang, Y., Srinath, A., Zhang, X., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20200895 · Cited by 120 · see citing works
Reifschneider, A., Robinson, S., van Lengerich, B., Gnörich, J., Logan, T., Heindl, S., Vogt, M. A., Weidinger, E., Riedl, L., Wind, K., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021109108 · Cited by 89 · see citing works
Stern, A. M., Yang, Y., Jin, S., Yamashita, K., Meunier, A. L., Liu, W., Cai, Y., Ericsson, M., Liu, L., Goedert, M., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.04.007 · Cited by 91 · see citing works
Jackson, R. J., Keiser, M. S., Meltzer, J. C., Fykstra, D. P., Dierksmeier, S. E., Hajizadeh, S., Kreuzer, J., Morris, R., Melloni, A., Nakajima, T., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.03.024 · Cited by 86 · see citing works
Pereira, J. B., Janelidze, S., Strandberg, O. T., Whelan, C. D., Zetterberg, H., Blennow, K., Palmqvist, S., Stomrud, E., Mattsson, N., & Hansson, O. (2022) · Nature Aging · doi:10.1038/s43587-022-00310-z · Cited by 82 · see citing works
Islam, F., Khadija, J. F., Harun-Or-Rashid, M., Rahaman, M. S., Nafady, M. H., Islam, M. R., Akter, A., Emran, T. B., Wilairatana, P., & Mubarak, M. S. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5100904 · Cited by 85 · see citing works
Inflammasome assembly in neurodegenerative diseases
Singh, J., Habean, M. L., & Panicker, N. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.07.009 · Cited by 83 · see citing works
Lee, S.-H., Rezzonico, M. G., Friedman, B. A., Huntley, M. H., Meilandt, W. J., Pandey, S., Chen, Y.-J. J., Easton, A. E., Modrusan, Z. D., Hansen, D. V., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110158 · Cited by 76 · see citing works
Self-citationMicroglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease
Yang, Y., & Zhang, Z. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00110 · Cited by 76 · see citing works
“TREM2 mutation or deletion will lead to abnormality of Wnt/β-catenin signaling and microglial dysfunction, which causes a high risk of AD (Zheng et al., 2017; Meilandt et al., 2020).”
BackgroundSchoch, K. M., Ezerskiy, L. A., Morhaus, M. M., Bannon, R. N., Sauerbeck, A. D., Shabsovich, M., Jafar-nejad, P., Rigo, F., & Miller, T. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2100356118 · Cited by 78 · see citing works
“Genetic loss of Trem2 in Aβ-depositing mice reduces microglial clustering around amyloid plaques (13–17), which may permit an increase in plaque load or pathogenesis (18, 42).”
BackgroundTesco, G., & Lomoio, S. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101628 · Cited by 91 · see citing works
Castranio, E. L., Hasel, P., Haure‐Mirande, J., Ramirez Jimenez, A. V., Hamilton, B. W., Kim, R. D., Glabe, C. G., Wang, M., Zhang, B., Gandy, S., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12821 · Cited by 74 · see citing works
Fruhwürth, S., Zetterberg, H., & Paludan, S. R. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578342 · Cited by 75 · see citing works
Wasén, C., Beauchamp, L. C., Vincentini, J., Li, S., LeServe, D. S., Gauthier, C. D., Lopes, J. R., Moreira, T. G., Ekwudo, M. N., Yin, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47683-w · Cited by 75 · see citing works
“…a reduction in Trem2 expression (means of normalized counts: 9.83 vs. 9.98, Wald test, p = 0.012, Fig.2D),whichisimportantforclearanceofplaquebymicroglia 22 anda reduction in Cathepsin L ( Ctsl , means: 0.61 vs. 9.01, Wald test, p >0.001) which is a degrading enzyme in the microglia lysosome 23 .”
InfluentialDysregulated Wnt Signalling in the Alzheimer’s Brain
Aghaizu, N. D., Jin, H., & Whiting, P. J. (2020) · Brain Sciences · doi:10.3390/brainsci10120902 · Cited by 70 · see citing works
“Three further Trem2-regulated genes—Wif1, Ctnna3 and Dkk2—can be categorised as negative regulators of Wnt signalling (note that Dkk2 can be a context-dependent activator and inhibitor of canonical Wnt signalling [47]) and their biological function in this context is most likely related to negative feedback [209].”
BackgroundResultInfluentialBelsare, K. D., Wu, H., Mondal, D., Bond, A., Castillo, E., Jin, J., Jo, H., Roush, A. E., Pilla, K. B., Sali, A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114486119 · Cited by 68 · see citing works
“Several in vivo studies show that TREM2 regulates polarization of microglial processes toward A β deposits, leading to plaque compaction and pacification in human AD brain samples and mouse models (17–19).”
Mo, Z., Zeng, Z., Liu, Y., Zeng, L., Fang, J., & Ma, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.914537 · Cited by 68 · see citing works
“TREM2 was found to prohibit β-catenin degradation, thereby activating the canonical Wnt pathway (Meilandt et al., 2020).”
BackgroundThe Role of P2X7 Receptor in Alzheimer’s Disease
Francistiová, L., Bianchi, C., Lauro, C. D., Sebastián‐Serrano, Á., de Diego-García, L., Kobolák, J., Dinnyés, A., & Dı́az-Hernández, M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00094 · Cited by 69 · see citing works
“Interestingly, recent studies have postulated that this protein plays a central role in the onset and the development of AD because microglia surround and enclose neuritic plaques in a TREM2-dependent manner (Wang Y. et al., 2015; Meilandt et al., 2020).”
BackgroundXue, F., & Du, H. (2021) · Cells · doi:10.3390/cells10020321 · Cited by 71 · see citing works
Microglia, Trem2, and Neurodegeneration
Shi, Q., Gutierrez, R. A., & Bhat, M. A. (2025) · The Neuroscientist · doi:10.1177/10738584241254118 · Cited by 69 · see citing works
“The impaired phagocytic activity leads to plaque accumulation, triggering neuroinflammation and neuronal damage (Meilandt and others 2020).”
TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies
Zhang, L., Xiang, X., Li, Y., Bu, G., & Chen, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00834-z · Cited by 78 · see citing works
“Studies in TREM2 KO PS2APP mice have shown that the absence of TREM2 leads to an increase in the Aβ42:Aβ40 ratio and the accumulation of soluble, fibrillar Aβ oligomers [87].”
Audrain, M., Haure‐Mirande, J., Mleczko, J., Wang, M., Griffin, J. K., St George‐Hyslop, P. H., Fraser, P., Zhang, B., Gandy, S., & Ehrlich, M. E. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12256 · Cited by 65 · see citing works
Delizannis, A. T., Nonneman, A., Tsering, W., Bondt, A. D., den Wyngaert, I. V., Zhang, B., Meymand, E. S., Olufemi, M. F., Koivula, P. P., Maimaiti, S., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01251-1 · Cited by 67 · see citing works
“Discussion The genetic linkage of microglial TREM2 loss-offunction variants with increased risk of AD has led to numerous studies [14, 22, 30, 46, 47, 52] characterizing the consequences of reduced TREM2 expression on Aβ pathology and plaque-associated neuritic damage.”
BackgroundResultInfluentialJairaman, A., McQuade, A., Granzotto, A., Kang, Y. J., Chadarevian, J. P., Gandhi, S., Parker, I., Smith, I., Cho, H., Sensi, S. L., et al. (2022) · eLife · doi:10.7554/elife.73021 · Cited by 61 · see citing works
Passive immunotherapy for Alzheimer's disease
Guo, X., Li, Y., Zhang, D., & Zhao, Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102192 · Cited by 66 · see citing works
“The phagocytic activity of microglia in pathological states depends on the activation of signaling pathways mediated by TREM2, which is expressed on the surface of microglia, and TREM2 deletion increases neuronal atrophy in PS2APP mice (Meilandt et al., 2020).”
BackgroundKim, D. W., Tu, K. J., Wei, A., Lau, A., Gonzalez-Gil, A., Cao, T., Braunstein, K. E., Ling, J. P., Troncoso, J. C., Wong, P. C., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00589-x · Cited by 66 · see citing works
Xu, Y., Au, N. P. B., & Ma, C. H. E. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.896852 · Cited by 63 · see citing works
“…that AD Mice with TREM2 haplodeficiency or TREM2-deletion led to the formation of more diffused Aβ plaques, which increased the area of contact between Aβ plaques and adjacent neurons resulting in exaggerated axonal damages in the surrounding tissues (Yuan et al., 2016b; Meilandt et al., 2020).”
BackgroundKarahan, H., Smith, D. C., Kim, B., Dabin, L. C., Al-Amin, M. M., Wijeratne, H. R. S., Pennington, T., Viana di Prisco, G., McCord, B., Lin, P. B.-C., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe3954 · Cited by 53 · see citing works
Adrian, M., Weber, M., Tsai, M., Glock, C., Kahn, O. I., Phu, L., Cheung, T. K., Meilandt, W. J., Rose, C. M., & Hoogenraad, C. C. (2023) · Nature Communications · doi:10.1038/s41467-023-41891-6 · Cited by 58 · see citing works
Self-citationEmre, C., Arroyo-García, L. E., Do, K. V., Jun, B., Ohshima, M., Alcalde, S. G., Cothern, M. L., Maioli, S., Nilsson, P., Hjorth, E., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03169-3 · Cited by 55 · see citing works
Castellani, G., & Schwartz, M. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.07.005 · Cited by 52 · see citing works
Reich, M., Paris, I., Ebeling, M., Dahm, N., Schweitzer, C., Reinhardt, D., Schmucki, R., Prasad, M. K., Köchl, F., Leist, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.617860 · Cited by 54 · see citing works
Tran, K. M., Kawauchi, S., Kramár, E. A., Rezaie, N., Liang, H. Y., Sakr, J., Gómez-Arboledas, Á., Arreola, M. A., da Cunha, C., Phan, J., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00598-4 · Cited by 50 · see citing works
“Consistent with the R47H variant inferring a loss-of-function phenotype, the initial microglia-plaque interaction is impaired, resulting in smaller and less compacted plaques yet an increase in dystrophic neurites produced by those plaques, in line with prior data from Trem2 KO mice [61, 62, 68].”
IL-4 and IL-10 promotes phagocytic activity of microglia by up-regulation of TREM2
Yi, S., Jiang, X., Tang, X., Li, Y., Xiao, C., Zhang, J., & Zhou, T. (2020) · Cytotechnology · doi:10.1007/s10616-020-00409-4 · Cited by 48 · see citing works
Codocedo, J. F., Mera-Reina, C., Bor-Chian Lin, P., Fallen, P. B., Puntambekar, S. S., Casali, B. T., Jury-Garfe, N., Martinez, P., Lasagna-Reeves, C. A., & Landreth, G. E. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114488 · Cited by 52 · see citing works
“35 This suggests that the attenuation of microglial activation induced by HK2 haploinsufficiency is consistent with improvement in AD pathology early in the adult stage.”
McFarland, K. N., & Chakrabarty, P. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01179-3 · Cited by 48 · see citing works
“APP/PS2 x Trem2 KO* 12, 22 mo ↓ Aβ ↑ degeneration [258]”
The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
Park, S., Lee, E.-H., Kim, H., Jo, S., Lee, S., Seo, S. W., Park, H.-H., Koh, S., & Lee, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-92101-6 · Cited by 48 · see citing works
Self-citationAlzheimer’s genes in microglia: a risk worth investigating
Sudwarts, A., & Thinakaran, G. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00679-4 · Cited by 46 · see citing works
“It regulates a protective microglial response to amyloid deposition in 5XFAD [37] and APP/PS2 [38] mice.”
BackgroundDisease-associated microglia in neurodegenerative diseases: Friend or foe?
Cheng, Y.-H., & Ho, M. S.-C. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003426 · Cited by 54 · see citing works
Dvir-Szternfeld, R., Castellani, G., Arad, M., Cahalon, L., Colaiuta, S. P., Keren‐Shaul, H., Croese, T., Burgaletto, C., Baruch, K., Ulland, T. K., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00149-w · Cited by 42 · see citing works
“One-way ANOVA was performed (F(4,49) = 6.”
Ren, X., Yao, L., Wang, Y., Mei, L., & Xiong, W. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02422-0 · Cited by 44 · see citing works
“The plaque diffuseness index was calculated by (Area6E10 − AreaThio-S)/ Area6E10, as described previously [22].”
MethodThe multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.
Kostes, W. W., & Brafman, D. A. (2023) · Cells · doi:10.3390/cells12081204 · Cited by 43 · see citing works
Henningfield, C. M., Arreola, M. A., Soni, N., Spangenberg, E. E., & Green, K. N. (2022) · Glia · doi:10.1002/glia.24105 · Cited by 40 · see citing works
“Previous studies have shown that global Trem2 or Apoe knock-out decreases plaque-associated microgliosis in multiple mouse models of AD (Bales et al., 1999; Jay et al., 2017; Krasemann et al., 2017; Meilandt et al., 2020; Wang et al., 2016) which is not seen with the model used in this study.”
ResultHuang, Y., Guimarães, T. R., Todd, N., Ferguson, C., Weiss, K. M., Stauffer, F., McDermott, B., Hurtle, B. T., Saito, T., Saido, T. C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204828119 · Cited by 37 · see citing works
INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model
Iguchi, A., Takatori, S., Kimura, S., Muneto, H., Wang, K., Etani, H., Ito, G., Sato, H., Hori, Y., Sasaki, J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106375 · Cited by 37 · see citing works
Ferguson, C. M., Hildebrand, S. R., Godinho, B. M. D. C., Buchwald, J. E., Echeverria, D., Coles, A. H., Grigorenko, A. P., Vangjeli, L., Sousa, J., McHugh, N., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13703 · Cited by 38 · see citing works
McKee, C., Hoffos, M., Vecchiarelli, H. A., & Tremblay, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125982 · Cited by 38 · see citing works
“Knocking out TREM2 in PS2APPmice, amodel of Aβ pathology, impairs microglia-mediated compaction of Aβ into dense plaques (Meilandt et al., 2020).”
BackgroundAPOE and immunity: Research highlights
Kloske, C. M., Barnum, C. J., Batista, A. F., Bradshaw, E. M., Brickman, A. M., Bu, G., Dennison, J. L., Gearon, M. D., Goate, A., Haass, C., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13020 · Cited by 36 · see citing works
“101 The researchers followed individuals receiving antihypertensive medications who had MCI at baseline and who had cognitive assessments during at least two follow-up visits to assess conversion to AD as well as cognitive and functional decline.”
Shen, Y., Liu, F., & Zhang, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117235 · Cited by 36 · see citing works
Microglial TREM2 at the Intersection of Brain Aging and Alzheimer’s Disease
Qu, W., & Li, L. (2021) · The Neuroscientist · doi:10.1177/10738584211040786 · Cited by 37 · see citing works
Byrnes, A. E., Domínguez, S. L., Yen, C., Laufer, B. I., Foreman, O., Reichelt, M., Lin, H., Sagolla, M. S., Hötzel, K., Ngu, H., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.05.005 · Cited by 35 · see citing works
“Analysis of positive stain area was performed using color thresholds and morphological operations as described previously.(67,68) Integrated optical density measurements were calculated by converting to grayscale intensity and applying Beer-Lambert law.”
MethodSelf-citationEtxeberria, A., Shen, Y.-A. A., Vito, S., Silverman, S. M., Imperio, J., Lalehzadeh, G., Soung, A. L., Du, C., Xie, L., Choy, M. K., et al. (2024) · The Journal of Neuroscience · doi:10.1523/jneurosci.2347-23.2024 · Cited by 34 · see citing works
Self-citationArdura-Fabregat, A., Bosch, L. F. P., Wogram, E., Mossad, O., Sankowski, R., Aktories, P., Kieger, L., Cook, J., Hasavci, D., Ulupinar, H., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02006-0 · Cited by 42 · see citing works
Eskandari‐Sedighi, G., Crichton, M. C., Zia, S., Gomez‐Cardona, E., Cortez, L. M., Patel, Z. H., Takahashi, K., Laurent, C. D. S., Sidhu, G., Sarkar, S., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00734-8 · Cited by 35 · see citing works
“Differences in plaque compaction have been shown to be associated with higher levels of Aβ induced neurotoxicity and worsened axonal pathology in humans as well as mouse models of amyloidosis [45, 46, 73, 107].”
BackgroundMicroglia and its Genetics in Alzheimer's Disease
Liang, X., Wu, H., Colt, M., Guo, X., Pluimer, B. R., Zeng, J., Dong, S., & Zhao, Z. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211105140732 · Cited by 31 · see citing works
Animal and Cellular Models of Alzheimer’s Disease: Progress, Promise, and Future Approaches
Trujillo‐Estrada, L., Sánchez‐Mejías, E., Sanchez-Varo, R. M., García‐León, J. A., Nuñez‐Diaz, C., Dávila, J. C., Vitórica, J., LaFerla, F. M., Moreno‐González, I., Gutiérrez, A., et al. (2021) · The Neuroscientist · doi:10.1177/10738584211001753 · Cited by 28 · see citing works
Neurodegenerative phagocytes mediate synaptic stripping in Neuro-HIV
Liberto, G. D., Égervári, K., Kreutzfeldt, M., Schürch, C. M., Hewer, E., Wagner, I., Pasquier, R. D., & Merkler, D. (2022) · Brain · doi:10.1093/brain/awac102 · Cited by 26 · see citing works
Roles of TREM2 in Alzheimer’s disease
Qi, X., Zhu, K., Ke, W., Wang, J., Mao, S., & Chen, G. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00515-3 · Cited by 36 · see citing works
“Therefore, TREM2 provides dual protection for synaptic integrity [176, 177].”
Knowledge gaps in Alzheimer's disease immune biomarker research
Morgan, D., & Mielke, M. M. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12342 · Cited by 25 · see citing works
Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells
Jing, H., Reed, A., Ulanovskaya, O. A., Grigoleit, J.-S., Herbst, D. M., Henry, C. L., Li, H., Barbas, S., Germain, J., Masuda, K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112971118 · Cited by 24 · see citing works
Differential Roles of TREM2+ Microglia in Anterograde and Retrograde Axonal Injury Models
Manich, G., Gómez‐López, A. R., Almolda, B., Villacampa, N., Recasens, M., Shrivastava, K., González, B., & Castellano, B. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.567404 · Cited by 26 · see citing works
“…during homeostasis and after injury (Cantoni et al., 2015; Poliani et al., 2015; Zheng et al., 2017), and impaired proliferation was observed in AD mouse models without TREM2 or harboring dysfunctional TREM2 variants (Jay et al., 2017a; Cheng-Hathaway et al., 2018; Meilandt et al., 2020).”
BackgroundRehman, R., Tar, L., Olamide, A. J., Li, Z., Kassubek, J., Böckers, T. M., Weishaupt, J. H., Ludolph, A. C., Wiesner, D., & Roselli, F. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.684171 · Cited by 23 · see citing works
“…reducing TREM2 signaling causes the reduced induction of DAM, which normally surround amyloid plaques and display active phagocytosis and lipid metabolism, with beneficial consequences on synaptic loss, amyloid peptides burden and dystrophic dendrites (Meilandt et al., 2020; Lee et al., 2021).”
BackgroundAPOEε4 and risk of Alzheimer’s disease – time to move forward
Lefterov, I. M., Fitz, N. F., Lü, Y., & Koldamova, R. P. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1195724 · Cited by 23 · see citing works
“What looks to be an undisputed feature of TREM2 is its role in microglia barrier around the amyloid plaques and in amyloid compaction (Wang et al., 2015; Yuan et al., 2016; Fitz et al., 2020; Meilandt et al., 2020; Wood et al., 2022).”
BackgroundShi, J., & Huang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010016 · Cited by 22 · see citing works
“TREM2’s role is underscored by the loss of microglial density and activation seen in TREM2-deficient or loss-of-function mutant models, highlighting its necessity for the formation of a protective microglial barrier around plaques [82,83].”
BackgroundTakatori, S., Kondo, M., & Tomita, T. (2025) · Inflammation and Regeneration · doi:10.1186/s41232-025-00383-4 · Cited by 23 · see citing works
“…TREM2 is crucial for microglial Aβ phagocytosis and metabolism, it is also deeply involved in mitigating amyloid toxicity through microglial clustering around amyloid plaques and promoting plaque compaction, which reduces the exposure of toxic Aβ species to surrounding neurons [13, 19, 31, 32].”
The effect of Abi3 locus deletion on the progression of Alzheimer’s disease-related pathologies
Karahan, H., Smith, D. C., Kim, B., McCord, B., Mantor, J., John, S. K., Al-Amin, M. M., Dabin, L. C., & Kim, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1102530 · Cited by 20 · see citing works
Wang, J., Du, L., Zhang, T., Chu, Y., Wang, Y., Wang, Y. T., Ji, X., Kang, Y., Cui, R., Zhang, G., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110006 · Cited by 22 · see citing works
Innate and adaptive immunity in neurodegenerative disease
Huang, Y., Zhang, G., Li, S., Feng, J., & Zhang, Z. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05533-4 · Cited by 21 · see citing works
Tolar, M., Hey, J. A., Power, A., & Abushakra, S. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052727 · Cited by 22 · see citing works
TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo
Lee-Gosselin, A., Jury-Garfe, N., You, Y., Dabin, L., Soni, D., Dutta, S., Rochet, J.-C., Kim, J., Oblak, A. L., & Lasagna-Reeves, C. A. (2023) · Cells · doi:10.3390/cells12121597 · Cited by 19 · see citing works
Zhao, Y., Guo, Q., Tian, J., Liu, W., & Wang, X. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102596 · Cited by 22 · see citing works
Qu, W., Jeong, A., Zhong, R., Thieschafer, J. S., Gram, A., & Li, L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03082-0 · Cited by 14 · see citing works
“In addition, to examine whether Hras deletion affects dendritic dystrophy, brain sections were subjected to immunostaining for Lamp1, a marker for late endosome that has been widely used to assess neurite dystrophy [26, 32].”
BackgroundMethodAyyubova, G. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15914 · Cited by 20 · see citing works
Bonomi, C. G., Assogna, M., Donna, M. G. D., Bernocchi, F., Lucia, V. D., Nuccetelli, M., Fiorelli, D., Loizzo, S., Mercuri, N. B., Koch, G., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221010 · Cited by 20 · see citing works
Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
Ibanez, K. R., McFarland, K. N., Phillips, J., Allen, M., Lessard, C. B., Zobel, L., De La Cruz, E. G., Shah, S., Vo, Q., Wang, X., et al. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01044-1 · Cited by 18 · see citing works
Changes in dendritic complexity and spine morphology following BCG immunization in APP/PS1 mice
Li, Q., Wang, X., Wang, Z. H., Lin, Z., Yang, J., Chen, J., Wang, R., Ye, W., Li, Y., Wu, Y., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2121568 · Cited by 19 · see citing works
“Studies have shown that cognitive impairment in AD is related to dendritic spine loss, especially in the hippocampus.(43,44) Specifically, dendritic spines are polymorphic structures that play a key role in the acquisition, integration, and transmission of nerve signals.”
BackgroundTREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential
Li, L., Zheng, X., Ma, H., Zhu, M., Li, X., Sun, X., & Feng, X. (2025) · Cells · doi:10.3390/cells14171387 · Cited by 20 · see citing works
Bace1 Deletion in the Adult Reverses Epileptiform Activity and Sleep–wake Disturbances in AD Mice
Yao, A. Y., Halloran, P. J., Ge, Y., Singh, N., Zhou, J., Galske, J., He, W., Yan, R., & Hu, X. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.2124-22.2023 · Cited by 21 · see citing works
“One speculation is that microglial compaction of amyloid into dense plaques may be a protective microglial activity (Meilandt et al., 2020), limiting the exposure of neurons to toxic Ab .”
Accelerated Aging Characterizes the Early Stage of Alzheimer’s Disease
Leparulo, A., Bisio, M., Redolfi, N., Pozzan, T., Vassanelli, S., & Fasolato, C. (2022) · Cells · doi:10.3390/cells11020238 · Cited by 17 · see citing works
PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology
Messenger, E. J., Baar, S. A., Bedford, L. M., Tsai, A. P., Lin, P. B., Ferguson, C. A., Xu, G., Wallace, A., Landreth, G. E., Lamb, B. T., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.70231 · Cited by 16 · see citing works
- Authors
- Meilandt, W. J., Ngu, H., Gogineni, A., Lalehzadeh, G., Lee, S.-H., Srinivasan, K., Imperio, J., Wu, T., Weber, M., Kruse, A. J., Stark, K. L., Chan, P., Kwong, M., Modrusan, Z., Friedman, B. A., Elstrott, J., Foreman, O., Easton, A., Sheng, M., & Hansen, D. V.
- Affiliations
- Genentech (US)
- Corresponding author
- Meilandt, William J.
- Hansen, David V.
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2020-01-24
- Volume
- 40
- Issue
- 9
- Pages
- 1956-1974
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC7046459
- OpenAlex
- W3003126983
- Semantic Scholar
- 24b2107485715864dc70c72f73ce957a07b3f7a9
- Cited by
- 210
- References
- 98
- Citations by year
- 2026: 16 · 2025: 30 · 2024: 44 · 2023: 48 · 2022: 33 · 2021: 25 · 2020: 14
- FWCI
- 18.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- TREM2, Alzheimer's disease, amyloid plaques, amyloid-beta 42/40 ratio, axonal dystrophy, dendritic spine loss, neuritic dystrophy, microglial activation, soluble amyloid-beta oligomers, neurofilament light chain, apolipoprotein E, Wnt signaling, sex differences
- MeSH terms
- Trefoil Factor-1, Alzheimer Disease, Animals, Axons, Female, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Peptide Fragments, Receptors, Immunologic, Amyloid beta-Peptides, Neurites, Amyloid beta-Protein Precursor, Neurofilament Proteins, Microglia, Mice, Knockout, Dendritic Spines, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review